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Infertility is an extraordinary public health problem, especially in our Arab 
world, affecting about 15% of couples seeking children. However, in 50% of 
these the male partner is responsible for infertility. Chromosomal anomalies 
and Y chromosome classical microdeletions in the azoospermia factor (AZF) 
regions are known to be associated with spermatogenic failure. In addition, 
partial AZFc deletions have been exposed to continuing intense debate on 
whether they cause spermatogenic failures or not. In the current study, 85 
patients with primary male infertility were studied in order to explore the 
cytogenetic and molecular background of male infertility in Gaza Strip of 
Palestine. Of the 85 infertile males, 8 patients (9.4%) showed chromosomal 
anomalies in the form of Klinefelter's syndrome [4/8, 50%], 47,XY,+mar 
[1/8,12.5%], 46,XY,del(17)(q25) [1/8,12.5%], 45,XY, Robertsonian fusion 
(15;21) [1/8,12.5%], and one with chromosomal instability that showed 
multiple mosaic karyotypes (1/8,12.5%). No Y chromosome classical 
microdeletions could be detected in any of the 85 infertile men, suggesting 
that ethnic factors, genetic background, and Y chromosome haplogroups are 
key factors in such deletions.  On the other hand, 6 gr/gr AZFc partial deletion 
cases (6/85, 7%) and one b1/b3 AZFc partial deletion pattern (1/85, 1.2%) 
were detected in the infertile group, while one gr/gr deletion was detected in 
the proven fertile controls (1/30, 3.3%).  
In conclusion, our study proves that cytogenetic analysis is mandatory in any 
diagnostic workup of infertile males. Moreover, our study shows that the 
incidence of Y chromosome microdeletions is rare in our population, 
suggesting that other genetic, epigenetic, nutritional and local factors may be 
responsible for idiopathic azoo/oligozoospermic in Gazian Palestinian 
population.  In addition, we suggest that gr/gr deletions may not be associated 
with male infertility.  
 
Key words: Male infertility, Chromosomal anomalies, Y-chromosome 
microdeletions, AZFc partial deletion  
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  :فلسطین-األسباب الجینیة لعقم الرجال في قطاع غزة
  Yي والحذف في كروموسوم موسومودراسة مشتركة تتضمن الخلل الكر
 
  :ملخص الدراسة
  
ن من األزواج الراغبی% 15العقم مشكلة صحیة عامة غیر اعتیادیة خاصة في عالمنا العربي اذ تصیب حوالي 
الكروموسومیة  االضطرابات و االعتالالت .من ھذه الحاالت% 50 مسئوًال عنیكون الرجل باإلنجاب و
قصورانتاج الحیوانات المعروفة بارتباطھا بمسببات ال من Y كروموسوم  منAZF الـ والحذف الكلي في مناطق
 Y في كروموسوم AZFcھذا باالضافة للجدل القائم حول كون القطع الجزئي لمنطقة  ،  وبالتالي العقمالمنویة
عن عقم الرجال األولي بھدف الكشف  مریضًا یعانون من 85شملت الدراسة .  أم المسببًا أیضًا لھذا القصور
 حیث أظھرت الدراسة وجود اعتالل. سطینالمسببات الكروموسومیة والجینیة لعقم الرجال في قطاع غزة بفل
بصورة متالزمة : موزعة كالتالي ممن شملتھم الدراسة  مرضىكروموسومي لدى ثمانیة
 (XXY ]8/4 ، 50%[،  ,XY,+mar47   ]8/1 ،12.5%[ ، ,46,XY,del(17) (q25,47)(كالینفلترز
]8/1 ،12.5%[ ، 45,XY, Robertsonian fusion (15;21) ]8/1 ،12.5%[، وحالة واحدة امتازت 
، 8/1[بتعدد انواع التشریط الكروموسومي وشخصت الحالة على انھا تعاني من عدم استقرار الكروموسومات 
 Yموسوم  من كروAZF مناطق الـفي الكلي  الخلل الناجم عن الحذف كما أظھرت الدراسة غیاب .]12.5%
ھم عوامل رئیسة في ) Y(في عینة الدراسة مفترضًا أن العوامل العرقیة والجینیة ونوع كروموسوم الذكورة 
 حاالت قطع جزئي في 6من الناحیة األخرى كانت ھناك . Yعملیات الحذف الكروموسومي في كروموسوم 
تم اكتشافھا %) b1/b3) 85/1 ،1.2وحالة واحدة من نوع %) gr/gr) 85/6 ، 7 من نوع AZFcمنطقة 
  %).3.3، 30/1 ( في العینة الضابطةgr/grفي عینة الدراسة المرضیة، بینما كانت ھناك حالة واحدة من نوع 
عقم لدى الرجال في ال والتشریط الكروموسومي لتشخیص حاالتإجراء الفحص كید وتأ  الدراسة لزومأستنتجت
من  AZF مناطق الواقع فيالكلي الناجم عن الحذف  الخلل كما أظھرت الدراسة ندرة حدوث. عنامجتم
 نعدام إنتاج الحیوانات المنویة أو إ لضعف في مجتمعنا مفترضًا وجود عوامل أخرى مسببةYكروموسوم 
محلیة وبیئیة، إضافة إلى ي الفلسطیني كعوامل جینیة أخرى وغذائیة و الرجال في مجتمعنا الغزِّعند) الالنطفیة(
  . وقصور انتاج الحیوانات المنویةgr/grمن نوع الجزئي  ارتباط بین الحذف  بعدم وجودفرضیتنا
  
  
، القطع الجزئي في Y، االعتالالت الكروموسومیة، الحذف في كروموسوم  الرجالعقم: الكلمات المفتاحیة
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       nfertility is a real extraordinary problem worldwide, especially in Arab 
cultures, since it exhausts the couples psychologically, socially, and 
emotionally; furthermore, it drains their financial resources. Infertility has been 
defined by the world health organization (WHO) as the inability to conceive 
naturally after at least one year of unprotected intercourse (Dohle et al., 
2004). It is estimated that as many as 15% of couples worldwide who seeks 
children suffer from infertility (Pryor et al., 1997; Tse et al., 2000; Dada et 
al. ,2003; Hellani et al., 2006).  
       Male causes for infertility are found in about 50% of infertile couples 
(Pryor et al., 1997; Ambasudhan et al., 2003). Reduced male fertility can be a 
result of congenital and/or acquired abnormalities. They include infections of 
the genital tract, varicocele, developmental and anatomical abnormalities, 
endocrinopathies, immunological factors, environmental exposures, and 
genetic abnormalities. Frequently, however, male infertility is difficult to 
diagnose, and about 60-75% of cases remain idiopathic. These idiopathic 
cases present with no previous history associated with fertility problems and 
have normal findings on physical examination (Dohle et al., 2004). 
       Contemporarily, a considerable and substantial attention has been 
focused on the role of genetic factors in spermatogenesis failure. It has been 
estimated that over 4000 genes are involved in the genetic control of human 
spermatogenesis (Gianotten et al., 2004). Some of them have been outlined 
and a number of genes related to infertility have been cloned, while other 
genes have been assigned to specific chromosome regions, but the majority 
of them remain undeciphered. Genetic anomalies causing male infertility can 
be roughly classified into three major groups: (1) chromosomal aneuploidies 
and rearrangements where batteries of genes on specific chromosomes have 
increased/decreased their expression dosage or changed their normal 
genomic environment; (2) interstitial deletions, whether microscopic or 
I  
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submicroscopic, where deletions or rearrangements of multiple genes 
mapped in a molecular neighborhood have changed their normal expression 
pattern, and (3) single gene defects where the expression of a single key 
element gene is changed or lost causing then male infertility (Vogt, 2004).  
       Aneuploidies can be easily diagnosed after performing G banding using 
trypsin and Giemsa (GTG) karyotyping. Therefore, GTG karyotyping is 
certainly a mandatory test in the diagnostic workup of any infertile man.    
       Interstitial deletions of the Y chromosome are the most common structural 
abnormalities. The majorities of these deletions are submicroscopic and can 
escape detection by GTG karyotyping. Therefore, only molecular techniques, 
such as polymerase chain reaction (PCR) can detect them. 
       The role of Y chromosome in male infertility was first elucidated in 1976 
when Tiepolo and Zuffardi have proposed the existence of a key factor which 
controls spermatogenesis encoded by a gene that is localized within the 
euchromatic region of the Y chromosome long arm (Yq11), which was called 
the azoospermia factor (AZF), because the first six men observed with 
microscopic terminal deletions in Yq, by routine karyotyping, were 
azoospermic (Tiepolo and Zuffardi, 1976). This substantially proved the close 
association between Y chromosome deletions and male infertility. In 1996, 
Vogt together with his colleagues have observed that Y chromosome 
microdeletions follow a certain deletion pattern, with three distinct recurrently 
deleted non-overlapping subregions in proximal, middle, and distal Yq11, 
designated "AZFa," "AZFb," and "AZFc," respectively. Many genes controlling 
spermatogenesis where mapped within these AZF regions (Foresta et al., 
2001). 
       Interstitial and terminal deletions in AZFa, or AZFb, or AZFc alone or in 
any combination of the Y chromosome long arm (Yq) are all associated with 
dramatic nonobstructive spermatogenic failure. Therefore, there is a clear 
cause-effect relationship between AZF loci deletion/s and male infertility (Reijo 
et al. 1996a; Simoni et al., 1998; Vogt, 1998; Foresta et al., 2001; Repping et 
al., 2002; Krausz et al., 2003; Krausz et al., 2006a; Fernando et al., 2006). 
These gross "microdeletions" are associated with divergent testicular 
histological profiles, ranging from Sertoli cell-only syndrome (SCOS), 
hypospermatogenesis (HS) to spermatogenic arrest (SGA) (Vogt et al., 1996). 
                                                                                                                                  Introduction 
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Apart from infertility, men presenting with AZF microdeletions appear 
otherwise healthy. These microdeletions are usually detected by performing 
sequence tagged site (STS) based PCR techniques on patient peripheral 
blood genomic DNA (Y chromosome microdeletion assay by PCR). Therefore, 
in addition to GTG karyotyping, Y chromosome deletion detection by PCR is 
also a mandatory test in the azoo/oligozoospermic patient workup.  
Worldwide, Y chromosome microdeletion assay has become a routine test 
(Ferlin et al., 2007). The literature estimate places about 10% cases of 
idiopathic azoo/oligozoospermia due to deletion in AZF regions, therefore, it is 
acknowledged as the most common molecularly diagnosable cause of 
spermatogenic failure in men with nonobstructive azoospermia or severe 
oligozoospermia (Reijo et al., 1995; Saxena et al., 2000; Kuroda-Kawaguchi 
et al., 2001; Foresta et al., 2001; Repping et al., 2003; Machev et al., 2004; 
Aknin-Seifer et al., 2004; Foresta et al., 2005). The literature also showed that 
complete deletion of the AZFc region which spans 3.5 Mb of the Y 
chromosome is the most common known genetic cause of human male 
infertility (Saxena et al., 2000; Kuroda-Kawaguchi et al., 2001; Fernandes et 
al., 2002; Repping et al., 2003; Machev et al., 2004; Nathanson et al., 2005; 
Fernando et al., 2006; Ferlin et al., 2007). 
       Yq11 human chromosome deletions most frequently occur as de novo 
mutation events in men with idiopathic azoospermia or oligozoospermia, 
therefore these deletions are not detected in their fathers or passed to their 
siblings. Some patients with these deletions can father, but usually not 
naturally, rather by assisted reproductive techniques, e.g., by testicular sperm 
extraction (TESE) in conjunction with intracytoplasmic sperm injection (ICSI) 
techniques. 
       Y chromosome microdeletion screening provides diagnostic, prognostic, 
and preventive impacts. In addition, it can improve genetic counseling. 
Moreover, infertile men are known to be at increased risk of androgen 
deficiency and testicular neoplasia (Giannouli et al., 2004; Nathanson et al., 
2005); however, whether the patients with Yq deletions have a greater risk 
also requires careful monitoring. 
       Apart from the aforementioned complete AZF region deletions (also 
called classical deletions), a new type of Yq deletion has recently attracted the 
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attention. Partial deletion patterns within the AZFc region have been proposed 
and then described. The spermatogenic effect of these deletions was found to 
vary among different populations.  
       Hitherto, no one has studied or characterized the genetic causes of male 
infertility in Gaza Strip (Palestine). To do so we have employed GTG 
karyotyping and PCR STS based techniques to detect the aforementioned 
genetic causes in the azoo/oligozoospermic Gazian patients. 
 
1.2. Aim of the study 
       The overall objective of the present study was to determine the 
prevalence of numerical and structural chromosomal abnormalities among 
idiopathic azoospermic and oligozoospermic infertile males in Gaza Strip. 
 
1.3. Objectives of the study 
• Establish the prevalence of numerical and structural chromosomal 
abnormalities that can be detected by GTG karyotyping in Gaza Strip 
azoospermic and oligozoospermic infertile men. 
• Get hands on experience in performing and interpreting GTG 
karyotyping. 
• Establish the prevalence and molecular characteristics of Y 
chromosome microdeletions in AZF subregions in Gaza Strip 
azoospermic and oligozoospermic infertile men. 
• Assess for the first time the occurrence of partial AZFc deletions in 
Palestinian men. 
• Establish the association between partial AZFc microdeletions and 
spermatogenesis failure. 















       Children are the usual and expected outcome of any legal and stable 
marriage relation. The inability to conceive naturally after one year of regular 
unprotected intercourse between married couples defines infertility by the 
WHO. It is estimated that approximately 15% of married couples are infertile 
according to the aforementioned definition (Pryor et al., 1997; Tse et al., 2000; 
Dada et al., 2003; Hellani et al., 2006). Infertility affects both men and women. 
Male factor either is a sole cause or contribute to the infertility problem in 
about 50% of the involuntarily childless couples (Pryor et al., 1997; 
Ambasudhan et al., 2003). 
 
2.2. Etiology of male infertility 
       Male infertility is manifested as quantitative abnormality (azoospermia, 
cryptozoospermia and oligozoospermia), or as qualitative abnormality 
(asthenospermia, teratozoospermia and necrospermia) or both (Hargreave, 
2000a; Ferlin et al., 2007). The causes of male infertility are numerous and 
can be divided into five major diagnostic categories: (i) disorders related to 
motility or sperm function; (ii) disorders related to obstructive lesions; (iii) 
disorders related to spermatogenic failure; (iv) sexual dysfunction disorders of 
erection and ejaculation; (v) endocrine dysfunction. Both environmental and 
genetic factors, combined or separate, have been suggested (Vogt, 2005a). 
No clear causal factor could be diagnosed in about 50% of cases coining the 
term "idiopathic male infertility". These men usually present with no previous 
history associated with fertility problems and have normal findings on physical 
examination. Genetic abnormalities contribute to a fair enough percentage of 
these idiopathic cases (Vogt, 2004). 
       Assessing male fertility potential starts with a thorough medical and 
reproductive history, a physical examination and a semen analysis. Whether 
the male partner is presenting with primary infertility (has never initiated a 
pregnancy in the past), most of the idiopathic male infertility cases are 
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categorized to this type,  or secondary infertility (has fathered a child with the 
same or a different partner in the past) may help to detect the specific cause 
of infertility. About 67-71% and 29-33% of patients have primary and 
secondary infertility, respectively (Irvine, 1998; Seshagir, 2001).       
       A past medical history can reveal information that is very helpful. Sexually 
transmitted diseases can result in obstruction of the tubular path. The 
childhood illness mumps may affect the testicles if contracted after puberty, 
causing mumps orchitis, which can result in severe inflammation of one or 
both testes with subsequent scarring, and reduces the ability of the testes to 
produce sperm.  
       Previous abdominal or scrotal surgical procedures, such as hernia repair 
or hydrocelectomy, can potentially block the transport of sperm. Traumatic 
injuries to the pelvis and testicles may also impair normal spermatogenesis or 
transport. Illnesses such as diabetes mellitus (DM) or respiratory tract disease, 
such as cystic fibrosis (CF), are in some cases associated with abnormalities 
of sperm transport as well. 
       Several environmental factors and agents such as heat, radiation, heavy 
metals, organic solvents and pesticides have been shown to affect 
spermatogenesis as have medications such as Azulfidine® (used for ulcerative 
colitis) and Tagament® (used for gastrointestinal ulcers), and the drugs 
caffeine, nicotine, alcohol, marijuana and cocaine. The antibiotic nitrofurantoin 
and others have been shown to inhibit sperm formation. 
       A thorough physical examination should be done, the testicles are 
assessed for normal size and consistency. Small, soft testes suggest impaired 
sperm production. The presence and consistency of the epididymis, and the 
presence of the vas deferens is confirmed. The vasa deferentia is also 
examined; as some men may have an absence, either partial or complete, of 
one or both vasa deferentia. The scrotum is examined for a varicocele, the 
most common cause of infertility in men (Pryor et al., 1997; Dohle et al., 2004).  
If present, a varicocele, which is an enlarged vein, allows blood to collect near 
the testicle, and consequently an abnormal amount of heat is transmitted to 
the testicle which may affect sperm production and production of the male 
hormone testosterone. A rectal examination is done to evaluate the prostate 
gland, which contributes fluid to the semen volume. 
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2.2.1. Idiopathic male infertility 
       Idiopathic male infertility is often associated with genetic and epigenetic 
abnormalities. The possibility that many cases of idiopathic male infertility 
might have genetic background was bolstered by the failure of most clinical 
therapies to correct deficient spermatogenesis (Silber et al., 1995b; Devroey 
et al., 1998). Genetic causes account for 10-15% of severe male infertility 
cases (Reijo et al., 1995; Vogt et al., 1996; Ferlin et al., 2006). Such 
abnormalities include chromosome translocations and aneuploidies, Y 
chromosome microdeletions, and androgenic receptor gene mutations. 
Numerous other genes are likely to be associated with male infertility. Initial 
reports from human studies have identified several candidate genes, including 
Protamine-1 and Protamine-2 genes, DAZL1, SPO11, EIF5A2, USP26, and 
others. Thus, genetic causes are either detected at the cytogenetic and/or at 
the molecular levels. In addition to gene mutations and polymorphisms, 
damage to the chromatin resulting in single and double strand DNA breaks 
affects male fertility. Epigenetic abnormalities such as gene imprinting also 
may contribute to male infertility. 
  
2.3. Chromosomal aberrations causing male infertility 
       Chromosomal aberrations whether numerical or structural are found in 
about 14% of azoospermic men and 5% of oligozoospermic men (Johnson, 
1998; Olesen et al., 2001; Foresta et al., 2002a; Vogt, 2004; Foresta et al., 
2005), these aberrations play a prime role in male infertility with abnormal 
semen parameters (Nagvenkar et al., 2005). Chromosomal aneuploidies and 
microscopic structural abnormalities are usually detected by cytogenetic 
methods, e.g., GTG karyotyping and Fluorescence Insitu Hybridization (FISH) 
techniques, but molecular techniques also can detect them such as Y 
chromosome microdeletions.  
       Most of the aneuploidies causing male infertility include one of the sex 
chromosomes, X and Y, whereby the karyotype 47,XXY which is associated 
with the Klinefelter syndrome (KFS) constitute the largest group. About 15% of  
KFS are classified as mosaic, with a 46,XY/47,XXY karyotype. Patients with 
KFS are characterized by testicular hypotrophy, azoospermia, elevated 
plasma FSH levels, and subnormal intelligence. However, severe 
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oligozoospermia occasionally may be present in patients with KFS, especially 
in those with the mosaic karyotype (Ferlin et al., 2006). There are few reports 
in which KFS patients have fathered biologically, but only through TESE and 
ICSI assisted reproductive techniques. (Tournaye et al.,1996) 
       Klinefelter patients with increasing number of X chromosomes, (48, 
XXXY) and (49,XXXXY), are KFS variants which shift their sexual phenotype 
to the female side. This suggests an X-chromosome dosage effect on the 
males gonad development, and also shows that the balance between X and Y 
chromosomes is crucial (Vogt, 2004). 
       Double Y chromosome men (47,XYY) are less frequent than the KFS with 
its variants, but with a variable infertility status, and if they are fertile their 
phenotype is usually oligozoospermia (Vogt, 2004). Characteristically these 
patients are aggressive in nature. 
       The mosaic karyotype 45,X0/46,XY leads to male infertility because of 
mixed gonad dysgenesis. It is found in infertile men with an incidence of 4%. 
Noteworthy, azoospermia and the karyotype 45,X0 (Turner syndrome) can be 
seen in men with AZFc deletions, this is because of terminal/distal deletion of 
the Yq11, rendering the Y chromosome unstable. Therefore, these patients 
belong to the AZF patient group. 
       Azoospermic men with the karyotype 46,XX (46,XX maleness, SRY-
positive XX male) are scarce in frequency and they are invariably sterile. 
AZFa, b, and c regions are all absent (AZFa-b-c deletion) in these men. These 
patients have fully mature male genitalia, normal height and unimpaired 
intelligenece (Ferlin et al., 2006). Intrestingly, Rajender et al. (2006) reported 
a case of SRY-negative 46,XX male with mature male genetalia but infertility. 
This case was also characterized by AZFa-b-c deletion. 
       Autosomal chromosomal anomalies, either aneuploidies, balanced 
Robertsonian translocations, balanced reciprocal translocations, balanced 
inversions, deletions, or extra markers were found less frequently than sex 
chromosome abnormalities (Vogt, 2004; Ferlin et al., 2006). Structural 
aberrations are found 10 times more frequently in infertile men than in the 
fertile men population (Vogt, 2004). 
       The most frequent structural chromosomal abnormalities in human is 
Robertsonian translocations and can affect male fertility. Robertsonian 
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translocations occur only between two acrocentric chromosomes (i.e., 
chromosomes #13, 14, 15, 21, and 22) which result in a single abnormal 
chromosome, generally, dicentric and contains most of the long arms of the 
original two chromosomes and subsequent loss of there short arms. The 
resulting balanced karyotype has only 45 chromosomes including the 
translocated one. In 60% of cases with Robertsonian translocations the two 
acrocentric chromosomes, 13 and 14, were involved (Vogt, 2004), the second 
most common is between chromosomes 14 and 21 (Ferlin et al., 2006). 
       Pericentric inversions in chromosomes 1, 3, 5, 6, and 10 are associated 
with reduced rate of sperm production and therefore may lead to male 
infertility. The expected phenotype ranges from oligozoospermia to 
azoospermia.  
       Male infertility caused by (Y;autosome) translocations have variable 
impact, since same karyotype was observed in fertile as well as in infertile 
men sometimes even within the same pedigree (Vogt, 2004). In most 
(Y;autosome) cases, the distal heterochromatin block of the Y long arm is 
translocated to the short arm of an acrocentric chromosome.  
 
2.4. The role of human Y-chromosome in male infertility 
       The Y chromosome is not essential for life, but also it is not a genetic 
wasteland. Its main task is to ensure that men can make and deliver sperm for 
the continuity of human species. In addition, the male sex determination role 
of the Y chromosome has been known for a long time, since it carries the sex 
determining region Y (SRY) gene, which switches the development of the 
indifferent gonad from the default female pathway to the male pathway, which 
results in the development of the testis (Goodfellow and Lovell-Badge, 1993; 
Yen, 2001). It harbors fewer genes through its 60 Mb length in comparison to 
the other 23 chromosomes, even when compared to its counterpart, the X 
chromosome (Carvalho and Santos, 2005).  
       In the human Y-chromosome, meiotic crossovers and recombination with 
the X chromosome take place only in its two relatively short regions, the Yp-
PAR1, and the Y-q-PAR2 (PAR= Pseudoautosomal region), found at the tips 
of Yp and Yq, respectively. The rest of the Y chromosome regions which 
compromise 95% of the entire Y chromosome are called NRY (Non-
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recombining region of the Y chromosome), which are flanked by the PAR1 
and PAR2. Skaletsky et al. (2003) renamed NRY to MSY (male-specific 
region of the Y chromosome) because they observed that the designation 
NRY did not reflect the dynamic evolutionary events occurring in this part of 
the Y chromosome.  
       The Y-chromosome is paternally inherited and forms 2-3% of the haploid 
genome, most of which is heterochromatic. The euchromatic portion of MSY 
only encompasses 23 Mb that contains 156 transcription units including 78 
protein-coding genes that collectively encode 27 distinct proteins (Skaletsky et 
al., 2003; Simoni et al., 2004). The MSY is made up of three main gene 
groups. The first group is composed of X-transposed genes, represented by 
two coding units approximately 99% identity to the corresponding X 
chromosome. The second group consists of 16 coding genes that are 
generally single-copy and expressed ubiquitously. These genes are involved 
in housekeeping cellular activities, and are probably involved in functions 
other than male reproduction. The third group is formed of ampliconic 
multicopy class genes that encompasses approximately 10.2 Mb distributed in 
Yp and Yq, which consists of large regions where gene copies show near 
absolute sequence identity (~99.9%), they are exclusively testis specific, and 
are implicated mainly in spermatogenesis and male fertility (Skaletsky et al., 
2003). 
 
2.4.1. Y- chromosome haplogroups and sperm count 
       Many Y-chromosome polymorphisms on the MSY, also called single 
nucleotide polymorphisms (SNPs) or unique event polymorphisms (UEPs), 
are biallelic markers, and can be combined in haplogroups that define Y 
chromosome lineage with specific geographic distributions around the world 
(Carvalho and Santos, 2005; Ferlin et al., 2006). These haplogroups are 
defined by the SNPs/UEPs, until now, more than 200 Y specific SNPs have 
been identified (Krausz and Degl'Innocenti, 2006b). Few published studies 
showed correlation between specific Y-chromosome haplogroups and low 
sperm counts. Krausz et al. (2001) have found that one class of Y 
chromosome referred to as haplogroup 26+ (hg 26+; or hg K according to 
YCC, 2002 nomenclature) was associated with unexplained reduced sperm 
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counts in individuals from the Danish population. Moreover, Kuroki et al. 
(1999) have also reported a haplogroup termed by the authors as Y 
haplogroup II (D2b according to YCC, 2002 nomenclature) to be more 
common in azoospermic Japanese men when compared with normal 
Japanese men. On the contrary, Carvalho and Santos (2005) did not detect 
any statistical association between Y-chromosome haplogroups and male 
infertility. In addition, Paracchini and co-workers (2000) failed to find any 
correlation between Y haplogroups and different sperm counts in Italian 
population. 
 
2.4.2. Y-chromosome: The interval deletion map 
       The Y chromosome has been divided by Vergnaud et al. (1986) into 7 
deletion intervals (1 to 7) (Fig.2.1):  the short arm and the centromere contain 
intervals 1-4, distal to proximal; the euchromatic part of Yq is represented by 
intervals 5 and 6, proximal to distal; the heterochromatic region is defined as 
interval 7. In 1992, Vollarth and colleagues further divided the seven intervals 
map into 43 subintervals, and this is the most commonly used map (Fig. 2.1) 
(Foresta et al., 2001; Dada et al., 2003). The 43 interval deletion map of 
human Y chromosome is based solely on PCR technology which contained an 
ordered array of DNA landmarks or specific monomorphic molecular markers 
that occurs only once in the human genome, called STSs (sequence tagged 
sites), across the entirety of the Y chromosome. These detailed molecular 
deletion mapping studies have explored many of the Y chromosome defects, 
especially deletions and microdeletions, in addition, it revealed there exact 




Figure 2.1. Y-chromosome: schematic presentation of the intervals that have been 
defined by deletion mapping and PAR 1 and 2 (adapted from Nabeel A. Affara, 2003). 
 
          1             2             3                 4                                     5                                         6            7 
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2.4.3. Y-chromosome long arm deletions and male infertility 
       Tiepolo and Zuffardi (1976) first observed human Y chromosome 
deletions that interfere with spermatogenesis causing male infertility and 
sterility 30 years ago (Tiepolo and Zuffardi,1976).  After the cytogenetic 
analysis of six azoospermic patients by Q banding (Quinacrine banding), 
terminal deletions of the long Y chromosome arm (Yq) were visible. This 
indicated that their Y deletions included the entire Yq12 heterochromatin block 
and an undefined amount of the adjacent active euchromatic part of Yq 
(Yq11.23). Furthermore, they found the fathers of two of their Y deleted 
patients carry a normal Y chromosome indicating that these deletions were de 
novo events. Consequently, the authors postulated that a key genetic Y factor 
critical for spermatogenesis is located within the distal Yq11, and its deletion 
was the cause of the azoospermia of their six patients. This factor was termed 
as the azoospermia factor (AZF). This also was then confirmed by additional 
numerous studies at both the cytogenetic and molecular levels (Vogt et al., 
1992; Ma et al., 1992; Ma et al., 1993; Nagafuchi et al., 1993). The results of 
these studies supported the concept that numerous Y chromosome genes 
impinge on spermatogenic maturation process of the male germ cell. In 1996, 
Vogt and co-workers screened 370 men with idiopathic azoospermia or 
oligozoospermia for deletions, using 76 STSs, and their findings suggested 
the existence of three nonoverlapping regions within the AZF locus; 
designated from proximal to distal, as "AZFa", "AZFb", and "AZFc", 
respectively. These regions have been mapped within the deletion intervals 5 
and 6 of the Y chromosome, which lie within Yq11.21-Yq11.23.  
       At least three different intervals (i.e., the AZFa, AZFb, and AZFc) on the Y 
chromosome long arm (Yq11) are critical for male germ cell differentiation. 
They encode specific genes essential for the normal complex process of 
spermatogenesis. These intervals vary in length as they also vary in the 
encoded genes. Most of the AZF encoded genes are testis specific. The exact 
role of the candidate AZF genes is largely yet unknown due to both the 
extreme rarity of naturally occurring AZF gene specific mutations and the lack 
of functional assays (Krausz et al., 2006a). Structural abnormalities in these 
intervals, notably microdeletion events, were found to be the most prominent 
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in azoospermic and oligozoospermic men with a normal karyotype (46,XY) 
(Reijo et al., 1995,1996a). These microdeletions are only detectable by 
molecular techniques, because the deletion length is less than to be 
visualized or discerned by routine cytogenetic methods, and this is why they 
are called microdeletions. Patients can show different deletion patterns, one 
or more AZF loci could be deleted (e.g. AZFb and AZFc), or even portions of 
variable lengths of one AZF locus may be deleted (partial microdeletions, e.g., 
gr/gr microdeletion, discussed below). Large scale of studies showed that the 
most frequently deleted region is AZFc, followed by deletions of the AZFb and 
AZF b-c or AZF a-b-c regions whereas deletions of the AZFa region are 
extremely rare (Saxena et al., 2000; Martinez et al., 2000; Tse et al., 2000; 
Foresta et al., 2001, Akbari Asbagh et al., 2003; Krausz et al., 2003; 
Ambasudhan et al., 2003; Yu et al., 2004; Carvalho and Santos, 2005; 
Fernandes et al., 2006; Omrani et al., 2006). Molecular studies have 
demonstrated that microdeletions at Yq11 (AZF loci) may represent the 
etiological factor in 10-15% of cases with idiopathic azoospermia or severe 
oligozoospermia (Reijo et al, 1995; Vogt et al., 1996; Ferlin et al., 2003). No 
clear correlation exists between the size and localization of the deletions 
within the AZF loci and the testicular phenotype. However, it is obvious that 
more widened deletions, as more genes are deleted, are associated with the 
most severe spermatogenic failure (Foresta et al., 2001). Most if not all of the 
deletions in the AZF loci are de novo in origin, i.e., they are not polymorphic 
events, which strengthen their pathogenic role in determining the 
spermatogenic disruption (Foresta et al., 2000). The transmission of these 
deletions to male offspring is obligatory, whether transmitted naturally or more 
often by assisted reproduction techniques (Oates et al., 2002; Hellani et al., 
2006). Quite surprisingly, Oates et al. (2002) reported a case of fraternal twins 
with AZFc deletion naturally conceived from an intact-AZFc father. On the 
other hand, there are few exceptional case reports in the literature that 
showed that AZF loci deletions can be naturally transmitted to the male 
offspring (Stuppia et al, 1996; Pryor et al., 1997; Chang et al., 1999;  
Kamischke, 1999; Saut et al., 2000; Rolf et al., 2002; Calogero et al., 2002; 
Gatta et al., 2002; Kuhnert et al., 2004).  These reports are contradicted only 
in one aspect, some of them showed that the deletions were identical with no 
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change or amplification between the father and his son(s) (e.g. Pryor et al., 
1997; Saut et al., 2000; Gatta et al., 2002; Kuhnert et al., 2004); whereas 
others showed that the deletions where more widened and amplified in the 
male offspring (e.g. Stuppia et al, 1996; Calogero et al., 2002). In this context, 
it is worth to note that few people who harbor these microdeletions can father 
naturally, which obviously shows the heterogeneity in phenotypes associated 
with the different microdeletion patterns, as it also exemplify the concept that 
fertility is not synonym of normal sperm count (Ferlin et al., 2007). Moreover, 
these previous reports demonstrated that the phenotypes in the sons were 
deleterious, since all of them were azoospermic, and no one could father 
naturally, i.e., only by assisted reproduction methods.  
       DNA sequencing of the Y chromosome has identified unique structural 
features, eight massive palindromes (mirror image sequences) within Yq 
being the most pronounced, designated 1 to 8, from distal to proximal, 
respectively (Fig.2.2.). Palindromes consisting of very long, near identical 
direct and indirect repeats, dubbed amplicons (Skaletsky et al., 2003). Most of 
the multicopy genes are contained within these palindromes. Recombination 
events between these amplicons is believed to be the cause of the high rate 
of the de novo Y long arm microdeletions that lead to infertility, for instance 
Kuroda-Kawaguchi et al. (2001) showed that 47 out of 48 men with AZFc 
deletion had the same proximal and distal breakpoints in 229 Kb amplicons 
flanking the AZFc region. This was strengthened and supported by the study 
of Repping et al. (2002) who showed that recombination between Yq 
repetitive palindromic regions can explain the majority of AZFb and AZFbc 
deletions. Then it was shown that intrachromosomal nonallelic homologous 
recombination (NAHR) events are recurrent in the MSY region, mostly at the 
AZFc locus, which explains the high incidence of AZFc locus deletion among 
other AZF loci (Fig.2.2) (Skaletsky et al., 2003; Repping et al., 2003; Machev 





Figure 2.2. The Yq massive palindromes map. 
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Fig. 2.3. Schematic display of the human Y-chromosome. Showing pseudoautosomal 
regions (PARS), the heterochromatic regions, the main genes on the euchromatic 
region, and the AZF regions associated with male infertility (adapted from Skaletsky et 
al., 2003, and Jobling and Tyler-Smith, 2003). 
 
2.4.3.1.1. The AZFa region   
       AZFa locus approximately spans 800 kb (Sun et al., 2000; Ferlin et al., 
2003). Three single copy genes were precisely mapped in the AZFa interval 
(deletion interval 5 C/D) named from proximal to distal Yq ubiquitin-specific 
protease 9, Y chromosome gene (USP9Y), DEAD box Y gene (DBY), and 
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(Sun et al., 1999; Foresta et al., 2000). The specific role of the three genes in 
human spermatogenesis is still to be elucidated, and it is debatable which of 
them is responsible for the AZFa phenotype. Interestingly, all of the three 
AZFa genes have an X chromosomal counterpart on the short arm (Xp11.4) 
which escape X inactivation (Vogt, 2004; Ditton et al., 2004; Singh et al., 
2005; Krausz and Degl'Innocenti, 2006b). 
       Both USP9Y and DBY deletions may cause testiculopathies, but Foresta 
et al. (2000) demonstrated that DBY gene is the fundamental major AZFa 
candidate because it is more frequently deleted than the USP9Y (i.e., partial 
AZFa deletion) and its absence produces a significant reduction of germ cells 
(marked hypospermatogenesis) or even their complete absence [sertoli-cell-
only (SCO)]. This has been also supported by Foresta et al. (2001) who stated 
that USP9Y is expressed widely in different tissues including the testes, while 
DBY have a testis specific transcript in addition to ubiquitous transcripts. Vogt 
(2005b) also suggested that the DBY gene is the major AZFa gene. This also 
could be further supported by Krausz et al. (2006a) who reported two different 
cases with two different de novo point mutations in the USP9Y gene causing 
an exon to be skipped and protein truncation, both cases are characterized by 
very mild testicular phenotype. On the light shed by this finding, they predicted 
that USP9Y is more likely to be a fine tuner that improves efficiency rather 
than a provider of an essential spermatogenic function. Moreover, heretofore, 
no reports showed an isolated deletion in the UTY gene (Foresta et al., 2000). 
Consequently, we can conclude that the DBY gene is the actual key player 
gene within the AZFa region, and its deletion is responsible for the AZFa 
phenotype in the AZFa region (Foresta et al., 2000; Ditton et al., 2004). 
Deletion of both the DBY and USP9Y genes may exacerbate the patient 
infertility status (Singh et al., 2005).  
       Deletions of the AZFa region are the least common class of AZF 
deletions, and are most frequently associated with azoospermic patients (Sun 
et al., 2000). Low frequency of AZFa deletions in comparison to the other AZF 
loci can be attributed to the more conventional and non-repetitive structure of 
the region. Although, intrachromosomal recombination events between two 
repetitive specific Human Endogenous Retroviral #15 (HERV15) sequence 
blocks flanking the AZFa region, HERV15q1 and HERV15q2, each ~10 Kb 
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long, are now believed to be the major cause of AZFa deletions (Fig.2.4) (Sun 






Figure 2.4. Schematic representation of the deletion mechanism in AZFa region. 
 
       Patients with AZFa deletion usually present with more severe phenotype 
than the most commonly encountered AZFc microdeletions. Complete 
deletion of the AZFa region is usually associated with complete Sertoli-cell-
only syndrome (SCO) in testicular biopsies (Vogt et al., 1996; Foresta et al., 
2001; Carvalho and Santos, 2005; Vogt, 2005b; Ferlin et al., 2006). Foresta et 
al. (2000) showed in their study that the incidence of AZFa deletions might be 
underestimated because they could detect AZFa partial deletions (isolated 
AZFa gene deletions) in infertile men in whom Y microdeletion test originally 
did not show deletion in any of the AZF loci. However, when they used the 
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2.4.3.1.2. The AZFb region 
       AZFb region spans approximately 6.2 Mb and usually mapped to the 
deletion subintervals 5O-6B, but this distance varies between individuals and 
according to the screening methodology (Foresta et al., 2001; Ferlin et al., 
2003; Vogt, 2004). The genes that have been mapped to the AZFb region 
include RBMY1, SMCY, eIF-1Y, PRY, RPS4Y2, HSFY, CDY2, TTY2, TTY5, 
TTY6, TTY9, TTY10, TTY12, TTY13, TTY14, TTY16, XKRY, CYorf14, 
CYorf15A and CYorf15B genes. Testes specific Transcript Y (TTY genes) are 
described as non-coding genes because they do not have an open reading 
frame (Lahn and Page, 1997; Skaletsky et al., 2003); while the role in 
spermatogenesis for most of the other genes is still to be elucidated. 
Originally, AZFb was considered a distinct Yq deletion interval (Vogt et al., 
1996); however, this was disproved by Repping et al. (2002) who showed that 
the previously considered non-overlapping AZFb region actually overlaps with 
the proximal part of the AZFc region by 1.5 Mb. The AZFb-AZFc overlapping 
interval includes seven extra genes, BPY2.1, CDY1a, DAZ1 (Deleted in 
Azoospermia), DAZ2, TTY3, TTY4, and TTY17, but these genes also have 
more copies distal to the AZFb, i.e., in the unique AZFc deletion interval (Vogt, 
2004). Repping et al. (2002) also demonstrated that homologous 
recombination between repetitive palindromic regions in Yq can explain most 
AZFb isolated deletions.  
       Several studies have proposed that the testis specific RNA Binding Motif- 
Y chromosome (RBMY1) gene family that encodes a nuclear protein 
represents the AZFb candidate (Ma et al., 1993; Chai et al., 1997; 
Mahadevaiah et al., 1998; Friel et al., 2002; Carvalho and Santos, 2005). This 
gene is highly expressed in mitotically active cells, thus may promote mitotic 
divisions in spermatogonia. Although there are numerous copies and 
pseudogenes (more than 30 copies) of RBMY1 on the Y, most of which are 
nonfunctional (Krausz and Degl'Innocenti, 2006b). However, there appears to 
be a functional copy in the region just proximal to AZFb/c overlapping region, 
with no rescue homolog elsewhere (Silber et al., 1998). On the other hand, 
the study of Ferlin et al. (2003) identified four infertile men with similar AZFb 
deletion breakpoints and all of them still retained the intact RBMY1 functional 
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copy (i.e., partial AZFb deletion proximal to RBMY1 gene) and all of them are 
represented with a testicular histology picture of either SCOS or marked 
hypospermatogenesis. This assumes that in addition to the RBMY1 gene 
there is/are other candidate gene/s within the AZFb region that is/are 
important in the core of the spermatogenesis process. Different studies have 
unveiled the assumed candidate gene to be the heat-shock transcription 
factor Y linked (HSFY) gene that is mapped in the palindromic sequence P4 in 
proximal AZFb; this gene encodes a novel heat shock protein. HSFY is a 
multicopy (2 copies), and is expressed exclusively in the testis, furthermore, 
its expression is restricted to both sertoli cells and spermatogenic cells. 
However, these studies did not define the exact deletion breakpoints. This 
gene was also found to be deleted in idiopathic azoospermic males (Shinka et 
al., 2004; Tessari et al., 2004; Carvalho and Santos, 2005; Vinci et al., 2005; 
Krausz and Degl'Innocenti, 2006b).  
       Complete AZFb deletions (also called classical AZFb deletions) are 
associated with recombination between palindromic sequences and removes 
6.23 Mb, which as mentioned earlier extend 1.5 Mb into the proximal portion 
of AZFc (Repping et al., 2002). Complete deletion of the AZFb region 
removes 13 Y genes completely and 10 Y genes partially with more copies 
located proximal and distal to the AZFb deletion interval (Vogt, 2004). Usually, 
complete AZFb deletions are associated with azoospermia manifested by the 
arrest of meiosis and maturation at the spermatocyte and spermatic stages of 
male germ-cell differentiation (Vogt et al., 1996; Krausz et al., 2000; Kamp et 
al., 2001; Affara, 2003; Vogt, 2004; Ferlin et al., 2007), although SCOS is not 
impossible. Likewise, combined AZFbc deletions are also a consequence of 
recombination between palindromic sequences. Although these deletions are 
large (~7.7 Mb), they do not include the distal portion of AZFc sequence 
(Repping et al., 2002). 
 
2.4.3.1.3. The AZFc region 
       AZF deletions occur most frequently in the AZFc region with an estimated 
population frequency of approximately 1 in 4000 males (Vogt et al., 1996; 
Saxena et al., 2000; Yen, 2001; Kuroda-Kawaguchi et al., 2001; Oates et al., 
2002; Skaletsky et al., 2003; Tyler-Smith and McVean, 2003; Repping et al., 
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2003; Machev et al., 2004; Nathanson et al., 2005; Fernando et al., 2006). 
AZFc region is composed entirely of palindromic direct and inverted 
ampliconic repeats of considerable unit length (115-678 kb) that only differ by 
~1nt per 3,000 bp. These rare subtle differences are called sequence family 
variants (SFVs) or single nucleotide variants (SNVs). This extraoridinary 
ampliconic structure of the AZF loci renders the region as a hot spot site for 
intrachromosomal ectopic homologous recombinations and subsequent 
spontaneous recurrent deletion errors (Skaletsky et al., 2003; Repping et al., 
2003; Machev et al., 2004; Vogt, 2005a). 
       Kuroda-Kawaguchi (2001) together with his colleagues constructed a 
meaningful map of the AZFc region after sequencing the entire AZFc region. 
They found that AZFc consisted of three palindromes with six distinct 
ampliconic families. These amplicons have been given the names: turquoise 
(t), gray (gr), green (g), yellow (Y), blue (b), and red (r) (Fig.2.5.).  
 
        
 
 





Figure 2.5. The reference ampliconic structure of the AZFc locus. AZFc amplicon 
structure is drawn according to the color code of Kuroda-Kawaguchi et al. (2001). Red 
stars numbered 1 to 4 show the location of the four DAZ genes. 
 
 
       As mentioned earlier, the AZFc region is delimited by two 229 Kb 
amplicons, proximal and distal, termed b2 and b4 (b for blue), respectively 
(see Fig.2.5.). Most of the AZFc deletions were between these two amplicons 
as witnessed by Kuroda-Kawaguchi et al. (2001) which spans approximately 
3.5 Mb and is mapped to the deletion intervals 6D-6F, which removes all of 
the AZFc locus. The association of b2/b4 complete AZFc deletions (also 
called classical AZFc deletion) with spermatogenic failure is well established 
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oligozoospermia (sperm count <5M/ml) to oligozoospermia (sperm count 5-20 
M/ml) (Ferlin et al., 2006; Repping et al., 2002; Foresta et al., 2001; Moro et 
al., 2000). 
       It was reported that patients with AZFc deletions and oligozoospermia will 
be exposed to a progressive decrease in their sperm counts overtime, as a 
result of spontaneous progressive regression of the germinal epithelium. This 
is why it is recommended for these patients to cryopreserve their semen for 
latter use when diagnosed avoiding the risk of becoming completely 
azoospermic or to avoid future more invasive techniques such as TESE/ICSI 
(Girardi et al., 1997; Simoni et al., 1997; Chang et al., 1999; Saut et al., 2000; 
Calogero et al., 2001; Dada et al., 2003; Ferlin et al., 2007), although this was 
discordant with Oates et al. (2002) findings who claimed that sperm 
production appeared to be stable over time in Y chromosome AZFc 
microdeleted patients.   
       Almost all b2/b4 AZFc deletions are essentially indentical in molecular 
extension, however, individuals carrying these microdeletions show variable 
grades of testicular failure, ranging from severe hypospermatogenesis, to 
SGA, to SCOS, although the former is the usual finding in testicular biopsies 
(Vogt et al., 1996; Oates et al., 2002; Arredi et al., 2007). It is of importance to 
know that mature spermatozoa (residual spermatogenesis) can generally be 
recovered from testicular tissue biopsies of azoospermic patients with AZFc 
deletions, whereas this usually is not the case in patients with complete AZFa 
or AZFb deletions (Saut et al., 2000; Vogt, 2005b). Consequently, TESE for 
ICSI treatment is not recommended for patients with complete AZFa or AZFb 
deletions, because usually they are unsuccessful (Krausz et al., 2000; Choi et 
al., 2004).  
       Genes within the AZFc region are present in multiple copies. The region 
includes 12 genes and transcription units each present in a variable number 
of copies making a total of 32 copies (Simoni et al., 2004). Candidate genes 
within the AZFc region include 4 copies of the DAZ (see below) , 3 copies of 
BPY2 (Basic Protein on Y chromosome,2), and two copies of CDY1 (CDY1a 
and CDY1b; Chromodomain protein, Y chromosome 1) (Reijo et al., 1995; 
Yen et al., 1998; McElreavey et al., 2000; Kuroda-Kawaguchi et al., 2001). 
The strongest candidate among them, in which its deletion is responsible for 
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the AZFc phenotype, is the DAZ gene family which encode putative RNA-
binding proteins, that are exclusively expressed in the male germ cells, 
specifically in the spermatogonia and early primary spermatocyte ( Menke et 
al., 1997; Saxena et al., 2000; Moro et al., 2000; Kuroda-Kawaguchi et al., 
2001; Repping et al., 2002; Oates et al., 2002; Ferlin et al., 2005; Carvalho 
and Santos, 2005). Noteworthy, DAZ gene family have no X chromosome 
homolog, but surprisingly have two autosomal homologs, DAZL1 (DAZ like-
autosomal 1) located on chromosome 3 short arm (3p24) and BOULE  
located on chromosome 2 long arm (2q33). DAZL is expressed exclusively in 
the germ cells where it encodes for a RNA binding protein (Foresta et al., 
2001; Ferlin et al., 2006). Therefore, it is suggested by Foresta et al. (2001) 
that DAZL1 may synergitically act in combination with DAZ during 
spermatogenesis. DAZL1 allows a small degree of spermatogenesis to 
survive in the majority of AZFc deleted men (Silber et al., 1998); which may 
explain the residual spermatogenesis in many AZFc deleted men. BOULE is 
also exclusively expressed in the testis, where it regulates meiosis through 
controlling the translation of CDC25 transcripts (Luetjens et al., 2004; Krausz 
and Degl'Innocenti, 2006b; Kostova et al., 2007). 
       There was a substantial argument about how many copies of DAZ gene 
are present within the AZFc region. Reijo et al. (1995) claimed that there is 
only one copy of DAZ, while Glaser et al. (1998), Yen et al. (1998), and Moro 
et al. (2000) suggested that there are seven copies. However, Saxena et al. 
(2000) demonstrated that there are at least four DAZ copies (DAZ1-DAZ4) 
found in two clusters. The proximal DAZ1 and DAZ2 (situated in P2 
palindrome) in one cluster, and the distal DAZ3 and DAZ4 (situated in the 
large P1 palindrome) in a second cluster, where the two genes in each cluster 
are arranged in two head-to-head clusters in amplicons r1-r4. This model was 
widely accepted and can explain why there is no point mutation events were 
detected within the DAZ genes, because if one is mutated the others will, of 
course, compensate (Ferlin et al., 2005; Lepretre et al., 2005; Fernandes et 
al., 2006). Lin (2005) together with here colleagues characterized 82 males 
with unknown fertility status for DAZ copy number by employing a novel DNA-
blot hybridization and FISH strategies. They found that most males have four 
DAZ genes, exactly as being described by Saxena et al. (2000). Importantly, 
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five out of these 82 males were found to harbor six DAZ genes. More 
importantly, two of these men were oligozoospermic, one fertile man, and two 
of unknown fertility status.  The question that remained to be answered what 
is the effect of the extra DAZ genes on male fertility? Noteworthy, DAZ genes 
are preferentially involved in quantitative rather than qualitative sperm 
production. Moreover, it does not affect or impair the leydig cell function 
(Mulhall et al., 1997; Oates et al., 2002).  
       Recently, a substantial attention was given to the CDY1 gene as being 
the second candidate gene within the AZFc region, which encodes a histone 
acetyltransferase (Vogt, 2005a). This gene is specifically expressed in the 
testis, which may signify its importance in spermatogenesis. CDY1 is present 
in two copies, CDY1a and CDY1b, within the AZFc region, one being 
embedded within the DAZ cluster, and the other is found within the distal 
AZFc region (Yen, 1998; Foresta et al., 2001; Machev et al., 2004; Giachini et 
al., 2005). Likewise DAZ, CDY1 has an autosomal homolog on human 
chromosome 13, called CDYL, in contrast to the DAZ autosomal homologs, 
this gene is expressed ubiquitously. (Foresta et al., 2001; Vogt, 2005a; 
Krausz and Degl'Innocenti, 2006b). 
 
2.4.3.1.4. Current modified classification of AZF region 
deletions 
       After the genomic human Y DNA sequence has been completed 
(Skalestsky et al.,  2003), it revealed the real genomic structure and 
organization of this extraordinary chromosome, the most interesting prominent 
features being the presence of eight massive palindromes (P) within the Yq, 
as described earlier. Moreover, and as mentioned before, most of the AZF 
microdeletions are generated through intrachromosomal homologous 
recombinations between amplicons organized into palindromic structures 
showing a nearly identical sequences. The original classification in the AZF 
regions (a,b and c) proposed by Vogt et al. (1996) was therefore modified 
according to the mechanism of deletion in: AZFa, P5/proximal P1 (previously 
known as AZFb), P5/distal P1 (previously known as AZF bc), P4/distal P1 
(also AZFbc), and b2/b4 AZFc (Fig.2.6.)[Repping et al., 2002]. 
 















Figure 2.6. Previous model of recurrent, interstitial Y-chromosome deletions that cause 
infertility in men (Vogt et al. 1996) contrasted with current model (figure not in scale) 
(Adapted from Repping et al. 2002). 
 
 
2.4.3.1.5. Incidence of AZF loci microdeletions 
       The incidence of Yq microdeletions in azoospermic and oligozoospermic 
infertile patients varies between studies, from 0% (Tzschach et al., 2001) to 
55% (Foresta et al., 1998) (see Table 2.1.). This variability could be attributed 
to all of the following: (1) Patient recruitment, selection and inclusion criteria; 
(2) Molecular testing methodology in relation to choice and number of STSs 
used, their position and their reliability. Furthermore, the lack of rigorous 
testing of negative results (false deletions); (3) Population differences due to 
different Y chromsome haplogroups; (4) Inappropriate diagnosis, and (5) Size 
of the study, studies with low patient number report a higher frequency of 
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Table 2.1. Y-chromosome microdeletions reported from 1995-2007 
Source No. patients No. deleted total pat.(%) No. STS 
Reijo et al., 1995 89 12 (13.5) 84 
Stuppia et al., 1996 33 6 (18.2) 14 
Reijo et al., 1996a 35 2 (5.7) 118 
Vogt et al., 1996 370 12 (3.2) 76 
Foresta et al., 1997 38 11 (29.0) 15 
Pryor et al., 1997 200 14 (7.0) 85 
Mulhall et al., 1997 83 8 (9.6) ? 
Girardi et al., 1997 156 8 (5.1) 36 
Van der Ven K, et al.,1997 204 2 (0.98%) 30 
Foresta et al., 1998 18 10 (55.5) 29 
Krausz et al., 1999b 134 3 (2.2) 7 
Tse et al., 2000 58 4 (6.9) 6 
Martinez et al., 2000 128 9 (7.0) 9 
Tzschach et al., 2001 97 0 (0.0) 13 
Peterlin et al., 2002 226 10 (4.4) 58 
Bor et al., 2002 400 3 (0.75) 25 
Ambasuhan et al., 2003 177 9 (5.1) 31 
Dada et al., 2003 83 8 (9.6) 6 
Gruber et al., 2003 187 0 (0.0) 18 
Asbagh et al., 2003 40 2 (5) 11 
Saopedro et al., 2003 60 4 (6.7) 13 
Bush et al., 2004 96 0 (0.0) ? 
Athalye et al., 2004 100 12 (12) 18 
El Awady et al., 2004 33 4 (12) 11 
Swarna et al., 2004 70 9 (12.8) 5 
Vicdan et al., 2004 208 19 (9.1) ? 
Okutman-Emonts et al., 2004 71 4 (5.6) 18 
Kihaile et al., 2005 113 7 (6.2) 24 
Kihaile et al., 2005 49 0 (0.0) 24 
Medica et al., 2005 105 1 (0.95) 9 
Hellani et al., 2006 247 8 (3.2) 19 
Fernando et al., 2006 96 7 (7.3) ? 
Omrani et al., 2006 99 24 (24.2) 18 
Hsu et al., 2006 460 24 (5.2) 4 
Pina-Neto et al., 2006 160 12 (7.5) 28 
Mohammed et al., 2007 266 7 (2.6) 35 
Imken et al., 2007 127 4 (3.15) 6 
 
2.4.3.1.6. AZF microdeletions association with Y haplogroups 
       Many researchers in the field either hypothesize or assume that certain Y 
chromosome haplogroups may predispose or protect against specific type of 
Y chromosomal microdeletions. For example, Vogt (2005a) assumed that 
different Y haplogroups have variable AZFb and AZFc molecular structures. 
This viariability may cause sequence differences or amplicons orientation 
differences, changing the frequency of intrachromosomal recombinations.  
However, a limited number of studies in the literature aimed to find the 
possible association of certain Y chromosome haplogroups with Y 
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chromosome microdeletions. In particular, the literature represents only five 
studies, up to date, which have investigated this possibility, all failed, except 
the most recent one, in individuating possible significant association, Table 
2.2. (Paracchini et al., 2000; Quintana-Murci et al., 2001; Carvalho et al., 
2003; Carvalho et al., 2004; Arredi et al., 2007). 
 
Table 2.2. Y chromosome haplogroups and AZF deletions association studies 
  No. of subjects analyzed   
Phenotype Population Patients Controls Main finding Reference 
AZF deletions European 73 299 No association Paracchini et al., 2000 
AZF deletions European 50 50 No association Quintana-Murci et al., 2001 
AZF deletions Japanese 6  84 No association Carvalho et al., 2003 
AZF deletions Israeli  9 - No association Carvalho et al., 2004 
AZFc deletions Italians 31  93 Association Arredi et al., 2007 
 
       Only, Arredi et al. (2007) novel study signaled for an association between 
Y haplogroup E and Y chromosome microdeletions in North Italian population. 
Y haplogroup E was found to be more prone to rearrangements, and in 
particular to b2/b4 microdeletions, than other Y haplogroups. On the contrary, 
such association could also be questionable, since Kihaile et al. (2005) 
studied  49 infertile African males and none of them showed any Y 
chromosome microdeletions, provided that Africans have a very high 
incidence of Y haplogroup E (Underhill et al., 2000; Y-Chromosome 
Consortium, 2002).  
       More intriguing, Arredi with his coworkers (2007) also figured out that the 
Y haplogroup J have a much reduced frequency among Y chromosome AZFc 
microdeleted patient group (1/31; 3.2%) than in the fertile normal group 
(14/93; 15%). The authors also stated in their study that Y chromosome 
belonging to this Y haplogroup confer protection against Y chromosome 
microdeletion occurrence because of the molecular characteristics of the J 
haplogroup. In particular, it does not contain the LIPA4 element in the 
HERV15q2 block which is supposed to facilitate the homologous 
intrachromosomal recombination leading to AZFa deletion. It is of importance 
to know that haplogroup J reach high frequencies in Middle East populations 
(Krausz and Degl'Innocenti, 2006b). 
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       For the timebeing, no conclusive results have yet been reached about the 
haplogroup role in association with Y microdeletions, and further studies in 
larger, well selected groups of subjects and geographical localization are 
indeed required to accredit such an attractive association with high certainity.  
 
2.4.3.1.7. Association of FSH and Inhibin B levels with AZF 
deletions 
        Testicular endocrine function in patients with AZF deletions showed 
serum FSH levels above the mean value, but are these raised levels 
specifically associated with microdeletions? Kumar et al. (2006) found raised 
serum FSH levels in all of his patients who have severe depletion in germ cell 
function, irrespective of the presence or absence of AZF deletions, and the 
levels were indeed correlated with the severity of the testicular histology. On 
the other hand, Frydelund-Larsen et al. (2002) studied FSH levels in 16 AZF 
microdeleted patients and found accordant high FSH levels in the majority of 
them. On the contrary, Foresta et al. (2001) and Ferlin et al. (2007) found low 
FSH levels in the AZF microdeleted patients when compared to infertile men 
without deletion. Furthermore, Frydelund-Larsen et al. (2002) and Krausz et al. 
(2001) found a uniformly low plasma inhibin B in AZF microdeleted patients, 
but again this was discordant with the findings of Foresta et al. (2001) who 
reported a relatively high level of plasma Inhibin B in patients with AZF 
deletions. From the above discordant findings, we can conclude that hormonal 
data are not useful in predicting Y chromosomal deletion patients.  
 
2.5. Partial AZFc deletions 
       The b2/b4 deletion takes out eight gene families including all members of 
the DAZ gene family, and carriers of such deletion have severe 
spermatogenic failure (Foresta et al., 2005; Lynch et al., 2005; Ferlin et al., 
2006). Recent data suggested that other nonallelic homologous 
recombination events could occur between amplicons within the AZFc region 
(Vogt, 2005a). These recombination events can yield to different AZFc partial 
deletion patterns; i.e., characterized by loss of some, but not all, copies of all 
AZFc genes. At first sight, some of these deletions appear to have little or 
even no effect on male fertility, whilst others appear to carry an increased risk 
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of developing spermatogenic failure (Ferlin et al., 2006). These partial AZFc 
deletions are reported in azoo/oligozoospermic infertile men as well as in 
normozoospermic fertile men. (Machev et al., 2004; Ferlin et al., 2005; 
Giachini et al., 2005; Lynch et al., 2005; Hucklenbroich et al., 2005; Carvalho 
et al., 2006; Ravel et al., 2006; Wu et al., 2007).  
       Different AZFc partial deletion patterns have been described, and 
thereafter termed (Fig.2.7.). They include gr/gr deletions (three subgroups: 
g1/g2, r1/r3, r2/r4) which remove 1.6 Mb, b1/b3 and b2/b3 (u3-gr/gr or g1/g3) 
deletions which remove 1.8 Mb, and other infrequent patterns (some are still 
not termed, but are  characterized  by  the  presence  or   absence  of  
different AZFc region specific STSs) (Fernandes et al., 2002; Repping et al., 
2003; Repping et al., 2004; Fernandes et al., 2004; Hucklenbroich et al., 
2005; Ferlin et al., 2005; Giachini et al., 2005; Ferlin et al., 2006). Each partial 
deletion pattern could also be further divided into subtypes, and although the 
number of gene copies deleted is the same, the missing type is different 
(Giachini et al., 2005). AZFc partial deletions could be detected and 
characterized by performing FISH, southern blotting, AZFc specific STSs PCR, 
DAZ-specific SNVs, or gene dosage analysis, which also allows to clarify the 
underlying deletion mechanism (Ferlin et al., 2006). 
       It is still very debatable whether partial AZFc deletions affect 
spermatogenesis or not. The gr/gr deletion described by Repping et al. (2003) 
removes about half of the AZFc region and it is thought by the authors to be a 
risk factor for spermatogenesis failure, but its penetrance is far lower than that 
of deletions involving the entire AZFc.  This suggests a polygenic dosage 
effect of multiple copy genes that might control spermatogenesis, as well as it 
may explain the reduction in sperm count. Ferlin et al. (2005) studied 337 
infertile and 263 control normozoospermic fertile Italian men for partial AZFc 
deletions. They found 19 cases of partial AZFc deletions, 18 cases (16 gr/gr 
cases, 1 b2/b3 case, and 1 b3/b4 case) within the infertile group, and only one 
case (with gr/gr deletion) among the control fertile group. On the basis of the 
increased prevalence of partial AZFc deletions in their infertile men group, 
they suggested that such deletions represent a risk factor for male infertility, 
de Llanos  et  al. (2005)  also   reached   the   same   conclusion   on   a study 
 
































Figure 2.7. Schematic representation of AZFc structure before and after complete and 
partial deletions. Red stars numbered 1 to 4 show the position of the four DAZ genes; 
a) AZFc classical b2/b4 deletion; (b and c) gr/gr partial AZFc deletions; d) b2/b3 partial 
AZFc deletion; e) b3/b4 partial AZFc deletion; f) b1/b3 partial AZFc deletion (Adapted 
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 conducted on Spanish population. Furthermore, Ferlin et al. (2005) 
performed SNV deletion analysis of DAZ genes on these deleted cases, and 
concluded that DAZ genes are only removed in doublets, either DAZ1/DAZ2 
or DAZ3/DAZ4. Most intriguing, they found that AZFc partial deletions 
removing DAZ1/DAZ2 doublets are associated with spermatogenic 
impairment. Also, Giachini et al. (2005) suggested on the basis of their work, 
that AZFc partial deletions are not specific for spermatogenic failure, but can 
be considered as a new risk factors  for  oligozoospermics.  Both  of  the  
latter studies were done on Italians, and both studies found gr/gr deletions to 
be more prevalant than other partial AZFc deletions, and most importantly 
both studies where in concordance concerning the functional importance of 
DAZ1/DAZ2 doublet in male fertility; Fernandes et al. (2002) also found 
DAZ1/DAZ2 gene doublet deletions only in men with severe oligozoospermia. 
However, Machev et al. (2004) found no difference in DAZ1/DAZ2 deletion 
frequency between infertile patient group and fertile control group, which 
appears to contradict this observation. Most interestingly, Giachini et al. 
(2005) also reported that deletion of the CDY1a copy was found only in the 
infertile group and was always associated with DAZ1/DAZ2 doublet deletion. 
A similar phenomenon has also been observed before in Machev et al. (2004) 
study performed on Mediterranean French population, which raises the 
importance of the CDY1a gene within the AZFc region in male fertility but this 
requires further confirmation.  
       Carvalho et al. (2006a), found no association between gr/gr deletions and 
male infertility in Brazilian white males, as also Zhang et al. (2006) and Wu et 
al. (2007) in Han-Chinese population, Fernando et al. (2006) in Sri Lankian 
population, and Imken et al. (2007) in Morroccan arab population. 
       Intristingly, Wu et al. (2007) found a strong association between b2/b3 
subdeletions, which removes DAZ3/DAZ4 doublet,  with male infertility in Han-
Chinese population. In this study, the prevalence of b2/b3 subdeletions in the 
infertile group (451 idiopathic infertile patients) was 8.9% compared to 3.2% in 
the normal control group (248 normal fertile males).  
       It is obvious from the previously mentioned studies that AZFc partial 
deletions could be compatible with male fertility, therefore they can be 
transmitted successfully from generation to generation. Consequently, they 
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are polymorphisms but not de novo rearrangements. This raises the question 
if they are associated with specific male lineage haplogroup/s. This sounds 
true, since Fernandes et al. (2004) identified that males with Y haplogroup N 
have consistently b2/b3 deletion (g1/g3 deletion) which removes DAZ3/DAZ4 
and BPY2.2/BPY2.3 doublets from the AZFc region without affecting their 
reproductive fitness; furtherance, proving the importance of DAZ1/DAZ2 
doublet in male fertility and/or may suggest that these genes are not required 
for male fertility. Haplogroup association could also be confirmed by the 
findings of Carvalho et al. (2006b) who reported that about 30% of Japanese 
males belong to the Y haplogroup D2b, and all of them were found to have a 
fixed gr/gr deletion that did not alter their sustained fertility status. In addition, 
Repping et al. (2003) studied 12 men belonging to the Y haplogroup D2b and 
all of them were found to harbor gr/gr deleted Y chromosome. Although the 
two latter studies are contradicted on the effect of the gr/gr deletions on male 
fertility, nevertheless, they were in concordance concerning the strong 
association of the gr/gr deleted Y chromosome with the D2b Y chromosome. 
More recently, Zhang et al. (2007) found a fixed gr/gr deletion in all infertile 
patients as well as in normal fertile donors belonging to the Y haplogroup Q1. 
Furthermore, Machev et al. (2004) suggested that the effect of the gr/gr 
deletion would vary on Y chromosome of different Y chromosome 
haplogroups, and that most of gr/gr deletions are neutral variants and would 
not affect male fertility. Same conclusion has also been reached by Giachini 
et al. (2005) concerning the b2/b3 AZFc partial deletions. 
       It was proposed by Zhang et al. (2007) that candidates with partial AZFc 
deletions, as polymorphisms, will have greater risk than others to give 
complete AZFc deletion offsprings, causing male infertility. 
       Quite surprisingly, a novel study conducted on Han-Taiwanese (Lin et al., 
2007) found that AZFc partial duplication is associated with an increased risk 
of impaired male fertility, but not the AZFc partial deletions. The authors 
attributed this finding to the increased expression of duplicated genes that 
may interfere with normal spermatogenesis. 
       For the moment, current literature showed that these AZFc partial 
deletion patterns still are subject to continuing intense debate and 
investigations, since contradictory and inconsistent, sometimes misleading, 
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findings were obtained with different recent studies. Moreover, published data 
cast doubts about AZFc partial deletions clinical relevance, consequently, it is 
still difficult to decide whether routine screening for partial AZFc deletions will 
be worthwhile (Repping et al., 2003; Machev et al., 2004; Fernandes et al., 
2004; Hucklenbroich et al., 2005; Ferlin et al., 2005; Giachini et al., 2005; 
Lynch et al., 2005; de Llanos et al., 2005; Carvalho et al., 2006; Zhang et al., 
2006; Ferlin et al., 2006; Ravel et al., 2006; Fernando et al., 2006; Wu et al., 
2007; Lin et al., 2007; Zhang et al., 2007).  
 
2.6. Diagnostic testing 
 
2.6.1. Semen analysis 
       When male infertility is suspected, then the conventional semen analysis 
begins the workup. A carefully performed semen analysis is a highly 
predictive indicator of the functional status of the male reproductive hormonal 
cycle, spermatogenesis and the patency of the reproductive tract.        
       Semen analysis will determine the volume of the ejaculate, concentration 
of sperm, the percentage of sperm with normal motility (swimming ability) and 
the percentage of sperm with normal appearance (morphology). Abnormality 
of any of these factors can be associated with infertility. If no sperm are found 
(azoospermia), the semen is analyzed for the presence of fructose, a sugar 
that is produced by the seminal vesicles. Its absence indicates obstruction 
along the reproductive tract. The WHO normal ranges for semen analysis  are 
shown in Table 2.3. 
 
Table 2.3. WHO-1999:  standard values for semen analysis 
Semen Characteristic Normal 
Volume (ml) ≥2 
pH 7.2-8.0 
Sperm Concentration (M/ml) ≥20 
Total Sperm Count (M/ejaculate) ≥ 40 
Motility ≥50% with progressive motility or 25% with 
rapid motility within 60 min after ejaculation 
Morphology (% normal) ≥ 14% of normal shape and form 
Viability  ≥ 50% of spermatozoa 
WBC (M/ml) < 1.0 
Immunobead test (IBT) <50% spermatozoa with adherent particles 
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2.6.2. Endocrinological evaluation  
       Most cases of male infertility are non-endocrine in origin. Routine 
evaluation of hormonal parameters is not warranted unless sperm density is 
extremely low or there is clinical suspicion of an endocrinopathy. The 
incidence of primary endocrine defects in infertile men is less than 3%. Such 
defects are rare in men with a sperm concentration of greater than 5 M/ml. 
When an endocrinopathy is discovered, however, specific hormonal therapy is 
often successful. A low testosterone level is one of the best indicators of 
hypogonadism of hypothalamic or pituitary origin. Low LH and FSH values 
concurrent with low testosterone levels indicate hypogonadotropic 
hypogonadism. Elevated FSH and LH values help to distinguish primary 
testicular failure (hypergonadotropic hypogonadism) from secondary testicular 
failure (hypogonadotropic hypogonadism). Most patients with primary 
hypogonadism have severe, irreversible testicular defects. On the other hand, 
secondary hypogonadism has a hypothalamic or pituitary origin and infertility 
may be correctable. Elevated FSH levels are usually a reliable indicator of 
germinal epithelial damage and are usually associated with azoospermia or 
severe oligozoospermia (sperm count < 5.0 M/ml), depicting significant and 
usually irreversible germ cell damage. In azoospermic and severely 
oligozoospermic patients with normal FSH levels, primary spermatogenic 
defects cannot be distinguished from obstructive lesions by hormonal 
investigation alone. Therefore, scrotal exploration and testicular biopsy should 
be considered. An elevated FSH level associated with small atrophic testes 
implies irreversible infertility, and a biopsy is not warranted.  
       The diagnostic value of prolactin measurement is extremely low in men 
with semen abnormalities unless these are associated with decreased libido, 
erectile dysfunction, and evidence of hypogonadism. Prolactin measurement 
is warranted in patients with low serum testosterone levels without an 
associated increase in serum LH levels. 
       Recently, plasma Inhibin B has been included in the male infertility 
workup especially in those patients with nonobstructive azoospermia. Inhibin 
B is secreted by sertoli cells in response to FSH, and is the major feedback 
regulator of FSH secretion in man. Plasma Inhibin B levels are closely 
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inversely correlated with FSH levels and may be regarded as sertoli cell 
function marker. In azoospermic patients of nonobstructive type, viable sperm 
extractions were successful in all patients with Inhibin B levels of greater than 
80 pg/ml, irrespective of their FSH, LH, or testosterone levels (Lockwood, 
2004). 
  
2.6.3. Conventional cytogenetics 
 
       Conventional cytogenetics (karyotyping) describes the chromosomal 
constitution. It is based on the recognition of metaphasic chromosomes 
according to their specific banding patterns. The most widely used cytogenetic 
staining is G-banding. G-banding is still an important routine method since it 
gives a comprehensive overview of genetic alterations. 
 
2.6.3.1. Basic cytogenetic procedures 
       Conventional cytogenetic studies require cells that are actively dividing. 
Specimens that contain proliferating cells are bone marrow, lymph nodes, 
solid tissues and chorionic villi. Peripheral blood lymphocytes require the 
addition of a mitotic stimulant (e.g. PHA, pokeweed) for the cells to undergo 
mitosis (stimulated culture). Chromosomes can be distinguished individually 
under the light microscope at metaphase. The choice of specimen for 
chromosomal analysis depends on clinical indication of the patient. In infertile 
male patients, which are our concern, the specimen of choice is peripheral 
blood sample. 
 
2.6.3.1.1. Specimen collection and handling 
       Human peripheral blood specimen must be collected into sterile tubes 
containing preservative-free sodium heparin. Specimen should be transported 
immediately at room temperature to the laboratory. If delay is unavoidable, 
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2.6.3.1.2. Culture media  
       Specimens for cytogenetic studies are grown in aqueous growth media, a 
variety of media are available, which include RPMI 1640, McCoy's 5A, MEM, 
and Ham's F10. Suspension culture media are balanced salt solutions 
containing salts, glucose, and buffering system to maintain the proper 
pH.  The culture media have to be supplemented with L-glutamine, fetal 
bovine serum (FBS) and antibiotics.  L-Glutamine is an amino acid essential 
for cell proliferation. Serum is essential for good cell growth. About 10-30% 
FBS is usually added to the culture medium. Penicillin and streptomycin are 
bacterial inhibitors commonly used in culture media to retard the growth of 
Gram positive and Gram negative microorganisms, respectively. Mitotic 
stimulants such as PHA (phytohemagglutinin: a T lymphocyte mitotic 
stimulant) is added to the culture media to stimulate cell proliferation. Blood 
samples which consist of free-floating cells can be cultured in sterile 
centrifuge tubes or tissue flasks. Most media are commercially available as 
powder and as concentrated or ready-to-use aqueous media. 
 
2.6.3.1.3. Specimen preparation for culture 
       Whole blood can be added directly to the culture medium or the white 
blood cells can be separated from the other blood elements (especially RBCs) 
and used to inoculate the culture medium. Separation of the white cells can 
be accomplished by centrifuging the sample or allowing it to rest undisturbed 
until the blood settles into three distinct layers. The lowest layer consists of 
the heavier red blood cells, the top layer consists of plasma, and the narrow 
middle layer, the buffy coat consists of the desired white cells, which can be 
removed and resuspend in culture media. Some cytogenetic practitioners add 
0.85% ammonium chloride to lyse RBCs (Verma and Babu, 1995). 
  
2.6.3.1.4. Cell harvest 
       After the cell cultures have been grown for 3 days, the metaphase cells 
are harvested. Harvesting involves collection of dividing cells at metaphase, 
hypotonic treatment, fixation, the placement of chromosomes on glass slides, 
so that they may be stained and microscopically examined. A mitotic inhibitor, 
colcemid that is an analogue of colchicine is usually used to obtain an 
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adequate number of cells at metaphase (increasing the mitotic index, MI). 
Colcemid binds to the protein tubulin, obstructing formation of the spindle 
fibers or destroying those already present. This prevents the separation of the 
sister chromatids in anaphase, thus collecting the cells at metaphase. 
Exposure time to colcemid is important. A longer exposure results in more 
metaphases being collected, but chromosomes will be shorter because they 
continue to condense as they progress through metaphase. Longer 
chromosomes are generally preferred for cytogenetic studies. 
       Hypotonic solution is added to the cells after exposure to colcemid. Water 
enters the cell by osmosis, thus causing the WBC cells to swell and RBCs to 
explode. This is critical for adequate spreading of the chromosomes on the 
slide. Timing is critical, too long an exposure will cause the cells to burst and 
too short an exposure will cause clumping of chromosome spreads. Examples 
of hypotonic solutions are 0.075M potassium chloride (KCl), 0.8% sodium 
citrate, diluted balanced salt solutions, and mixtures of KCl and sodium 
citrate. Morphology of the chromosomes is affected by the type of hypotonic 
solution used. 
       Fixative containing three parts of absolute methanol to one part glacial 
acetic acid (modified Carnoy’s solution) is used to stop the action of the 
hypotonic solution and to fix the cells in the swollen stage. The fixative also 
lyses any remaining RBCs present in the sample, furthermore it ensures the 
removal of cytoplasm together with cell debris. The fixative must be prepared 
fresh before use because it absorbs water from the atmosphere. The fixed cell 
suspension is dropped onto glass slides.  The concentration of the cell 
suspension can be adjusted to achieve optimal results. A good slide 
preparation has sufficient number of metaphases that are not crowded on the 
slide, metaphases that are well spread with minimal overlapping of the 
chromosomes, and no visible cytoplasm. Increased temperature and humidity 
enhance chromosome spreading, whereas cooler temperature and 
lower humidity decrease it. Longer exposure to hypotonic treatment makes 
the cell more fragile and thus increases spreading, but an inadequate 
exposure can result in cells that are difficult to burst.  Variables in slide 
preparation include the height from which the cells are dropped; the use of 
wet or dry slides; the use of cold, room temperature, or warm slides; the use 
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of steam; air- or flame-drying  the slides;   and the angles at which the slide 
and/or pipette is held.  The slides are ‘aged/baked' for two days at 56-60 ºC or 
for 1-2 hour at 90 ºC to enhance chromosome banding. Chromosomes can 
also be ‘aged’ by brief exposure to UV light or to Microwave oven (Sole and 
Woessner, 1992). 
 
2.6.3.1.5. G banding and staining 
       G banding techniques create bands along the length of the chromosome. 
This property facilitates the positive identification of the individual 
chromosome pairs and permits the characterization of structural 
abnormalities. Banding resolution is an estimate of the number of light and 
dark bands in a haploid set (number of bands visible on 23 chromosomes, 
one of each autosomal pair and the X chromosome). The minimum estimate 
is about 400 bands. Well-banded, moderately high-resolution metaphases are 
usually in the 500-550 band level, and prometaphase cells can achieve a 
resolution of 850 or more bands (high resolution banding). High resolution 
banding facilitates a better karyotype analysis and more precise designation 
of breakpoints and subtle chromosomal abnormalities. 
       GTG banding is one of the several G-banded techniques and the most 
common. The ‘aged’ slides are treated with the proteolytic enzyme trypsin and 
stained with Giemsa. Besides Giemsa stain, Wright's or Leishman stain can 
be used.  A series of alternate light and dark bands will be produced along the 
length of each chromosome. These banding patterns are the barcodes which 
enable the positive identification of each chromosome. The dark bands are A-
T rich, late replicating, heterochromatic regions of the chromosomes, whereas 
the light bands are G-C rich, early replicating, euchromatic regions. The G-
light bands represent the most active regions of the chromosomes compared 
to the G-dark bands which contain relatively few active genes. G-banding is 
routinely used for the clinical evaluation of human chromosomes in most 
laboratories. Its permanent nature (in comparison to Q banding) facilitates a 
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2.6.3.1.6. Karyotyping automation 
       Labor intensive is the remarkable disadvantage of conventional 
cytogenetic techniques. Instruments such as robotic harvesters, 
environmentally controlled drying chambers, and computerized imaging 
systems have been developed to assist the cytogenetic laboratory in sample 
preparation and chromosome analysis. The Cytogenetics Laboratory at the 
Islamic University uses the computerized imaging system since 2005. Except 
for the imaging system, the other techniques for cytogenetic studies at the 
Islamic University cytogenetic laboratory are all virtually performed manually. 
       The traditional method of karyotyping involves photomicroscopy after the 
location of suitable metaphases. A camera is attached on top of the 
microscope to take photographs of the metaphase spread. The film and 
photographs are processed in a dark room. The metaphase spreads are cut 
and paired, then stuck on a karyotype card. Karyotyping by this procedure is 
time consuming. The process now has been superseded by a computerized 
imaging system. An image acquisition subsystem can be used to capture the 
metaphase spreads.  The subsystem consists of a microscope camera 
adapter, a charged couple device (CCD) camera, a frame grabber and image 
capture software. Dedicated cytogenetic imaging software can 
perform karyotyping; banding analysis and ideogram display are all now 
commercially available. At the Islamic University-Gaza cytogenetic laboratory, 
the computerized imaging system used is the Applied Spectral Imaging 
system. Metaphase spreads are captured in the digital form by the capture 
station. The image is then transferred to the system workstation where 
karyotyping is performed. Karyotyping is performed semi-automatically. The 
cytogenetic practitioners have to check the karyotypes manually to ensure 
that the chromosomes are correctly paired. A printer produces a hardcopy of 
the metaphase spread and karyotype. The images consisting of metaphase 
spreads and karyotypes are stored as digital files on the optical disks. 
       Karyotyping is done by following the guidelines laid down by the 
international system for human chromosome nomenclature (ISCN, 1995), 
which is the definitive guide to terminology and writing of the karyotype. All 
metaphase spreads should be analyzed, and at least two karyotypes should 
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be prepared. If more than one cell line is present (i.e., mosaics), at least one 
karyotype must be prepared from each cell. The resolution should be at least 
400 bands. When there are less than 20 analyzable cells and an abnormality 
has been detected, the number of abnormal and normal cells (if any) is 
reported. When fewer than 20 cells can be examined and an abnormality is 
not detected, the number of cells studied is reported and additional 
procedures (FISH, molecular studies) may be recommended if clinically 
appropriate.  
 
2.6.4. Polymerase chain reaction (PCR)  
       The polymerase chain reaction (PCR) was invented in 1985 by Kary 
Mullis at Cetus Corporation. The PCR can amplify a small segment of DNA 
over a billionfold. The method uses a pair of oligonucleotide primers, each 
about 15 to 50 base pair (bp) in length designed to hybridize to opposite 
strands of DNA at sites of several kilobases (kb) apart. In the presence of 
deoxyribonucleotide triphosphates (dNTPs), DNA polymerase, and buffer the 
oligonucleotides prime the synthesis of DNA on the DNA template.  The PCR 
is based on the repetition of a number of cycles, each cycle comprising of a 
set of 3 steps, heat denaturation, annealing of primers, and primer extension, 
all conducted in succession under different and controlled temperature 
conditions. In heat denaturation, the double stranded DNA (template) is 
denatured by heating to a high temperature that causes the two strands to 
dissociate. Annealing of primers, since the primers are present in excess over 
the DNA templates, the formation of the primer-template complex will be 
favored over the reassociation of the two DNA strands when the temperature 
is lowered. Primer extension (amplification step), the third step is the 
synthesis of a strand of complementary DNA, through the 5’ to 3’ extension of 
each annealed primer. The 3 steps can be accomplished automatically with a 
thermal cycler. Usually 25 to 35 or more cycles are performed.  In each cycle, 
the DNA fragments synthesized in the previous cycles becomes templates for 
the new DNA synthesis.  The DNA fragments accumulate exponentially at a 
rate of 2n, where n equals the number of cycles performed. The PCR products 
are DNA of uniform length that spans the distance between the sites of 
oligonucleotide priming.  The ends of each amplified DNA fragment (also 
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known as target sequence product or amplicon) have nucleotide sequences 
that correspond to that of the oligonucleotide primers. However, the 
exponential amplification is not an unlimited process. A number of factors act 
against the process being 100% efficient at each cycle. Their effect is more 
pronounced in the latter cycles of PCR. The amount of enzyme becomes 
limiting after 25-30 cycles of PCR due to molar target excess. The enzyme 
activity is also reduced due to thermal denaturation. As the concentration of 
the target strands increases, it competes with primer annealing by 
reannealing of target strands. The PCR can amplify DNA fragments that are 
smaller than 5 kb. For large DNA fragments, PCR is inefficient due to the 
difficulty of synthesizing DNA of sufficient length from one primer to serve as a 
template for the other primer in the next amplification cycle. The PCR has 
found many applications such as the diagnosis of disease states, species 
identification, and detection of viral or bacterial infection, prenatal diagnosis, 
and forensic sciences.  
       The basic components of the PCR are the DNA template, DNA 
polymerase, dNTPs, primers, magnesium chloride (MgCl2), and buffer. The 
various reagents are available commercially and some come in kit form.   
       Confirmation of PCR products are usually resolved by ethidium bromide 
stained agarose gel electrophoresis and viewed under ultraviolet (UV) light. 
PCR products can also be confirmed by restriction endonucleases (this 
depends on the presence of a suitable restriction site within the amplified 
sequence). PCR may yield false-positive reactions. Either false priming can 
occur on the genomic DNA or on the primers themselves, resulting in 
amplified fragments containing irrelevant DNA. The amplified product can be 
further confirmed by Southern Blot analysis of the PCR products followed by 
hybridization with the appropriate DNA probes, or a second round of PCR can 
be performed on the amplified DNA fragments using ‘nested’ oligonucleotide 
primers that correspond to such internal sequence (nested PCR). 
       Y chromosome microdeletions can be detected by PCR using the 
different STSs distributed along the Y chromosome, these STSs are 
distributed every ~30 kb (Aknin-Seifer et al., 2004) and enable detection of 
small deletions in the AZF regions that were undetectable with classical 
cytogenetic techniques.  




MATERIALS and METHODS 
 
 
3.1. Study population 
       In the present study, 86 consecutive infertile Palestinian males residing in 
Gaza Strip with nonobstructive azoospermia (zero sperm count), 
cryptozoospermia (sperm count <0.1 M/ml), severe oligozoospermia (sperm 
count >0.1 and < 5 M/ml), or oligozoospermia (sperm count 5-10 M/ml) were 
selected and recruited from assisted reproduction centers and private 
infertility clinics, during the period from June 2006 to August 2007. Patients 
presented with primary infertility and having sperm counts less than 10 M/ml 
on 2 consecutive occasions, at least, were our candidates for the present 
study. One patient was omitted (case# 21) from our study because his 
azoospermia was later been found to be due to obstruction. A scheduled 
interview for each patient have been arranged to collect demographic data, 
past medical history, including history of chemotherapy, radiotherapy, 
varicocele, and cryptorchidism, and habits concerning smoking, alcohol 
consumption, and drug intake.  Semen analysis results were collected for 
each patient. In addition, hormone profile (FSH, LH, total testosterone, 
prolactin, and Inhibin B) and histological testicular biopsy reports were 
collected, whenever available.  
       The proven fertility control group consisted of 30 Gazian men with proven 
fertility, defined as naturally conceiving at least one child. DNA extracted from 
there ethylenediaminetetraacetic acid (EDTA) blood samples were only 
analyzed for the presence of AZFc partial deletions. 
       Testing for the origin of the AZFc partial microdeletions (i.e., inherited or 
occurring de novo) was only possible for 4 patients, because blood from 
patients' fathers or brothers was not always available. DNA extracted from the 
available relatives EDTA blood samples were only analyzed for the presence 
of AZFc partial deletions. 
 




3.2.1. Chemicals and reagents 
       Chemicals and reagents used in this study are shown in Table 3.1. All 
chemicals were of analytical and molecular biology grade. 
Table 3.1. Chemicals and reagents used in the present study 
Reagent Supplier 
Wizard® Genomic DNA Purification Kit Promega, Madison, WI, USA  
PCR Master Mix Promega, Madison, WI, USA 
Go Taq® Green Master Mix  Promega, Madison, WI, USA 
Agarose Gel Promega, Madison, WI, USA 
Nuclease free water Promega, Madison, WI, USA 
DNA molecular size marker (Ladder), 100bp (1) Promega, Madison, WI, USA 
(2) BioLab, New England 
PCR primers (1) Operon (Germany) 
(2) IDT (USA) 
Ethidium Bromide (EtBr) 10mg/ml Promega, Madison, WI, USA 
COLCEMID SOLUTION (10 μg/ml) Biological Industries, Israel 
POTASSIUM CHLORIDE SOLUTION (0.075M) Biological Industries, Israel 
Trypsin EDTA (10x) Biological Industries, Israel 
HANKS' BALANCED SALT SOLUTION 
 Without Calcium and Magnesium 
Biological Industries, Israel 
METHANOL, Absolute, Acetone Free Frutarom, Israel 
GLACIAL ACETIC ACID Chembal Company, Gaza Strip 
PCR Loading Solution (Bromophenol Blue) (6x) 
 
0.25% Bromophenol blue 40% (w/v) 
sucrose in water 
Tris-Acetate-EDTA (TAE) (50x) 2M Tris base (pH 8), 1M Glacial Acetic 
Acid, 0.05M EDTA (pH 8) 
Leishman Stain Sigma, USA 
Culture grade water Biological Industries, Israel 
 
3.2.2. Culture media 
       Ready made RPMI1640 suspension medium supplemented with L-
glutamine, fetal bovine serum (FBS), antibiotics, and  phytohemagglutinin was 
used for culturing peripheral blood lymphocytes (PERIPHERAL  BLOOD 
KARYOTYPING MEDIUM (RPMI 1640)  with phytohemagglutinin, Biological 
industries, Israel).  
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3.2.3. Disposables 
       The major disposables used in this study are listed in Table 3.2. 
                            
Table 3.2. Major disposables used in the present study 
Item Item 
Falcon Screw Cap Sterile Tubes 15 ml Microfuge tubes - 1.5 ml capacity 
PCR Microfuge tubes for PCR - 0.2 ml capacity Gauze 
Standard size precleaned glass slides Disposable Gloves 
Disposable Micropipette tips to deliver 1-5000 µL EDTA Tubes 
Sodium Heparin Tubes Weighing cups 
 
3.2.4. Equipment 
       All experiments of this study were done at the Islamic University of Gaza- 
Genetics Laboratory. The major equipment that were used are listed in Table 
3.3. 
Table 3.3. Major equipment used in the present study 
Instrument Manufacturer 
Thermocycler Eppendorf, Germany 
Biometra, Germany 
Electrophoresis chambers/tanks BioRad, USA 
Electrophoresis power supply BioRad, USA 
Microcentrifuge Sanyo, UK 
Microwave LG, Korea 
CO2 Incubator N-BIOTEK, INC, Korea 
Bench top Centrifuge LWScientific, USA 
Bench top Cooled Centrifuge Centurion Scientific LTD, UK 
Water Bath PSELECTA, Spain 
pH Meter Sartorius, Germany 
Phase Contrast Microscope MEIJI Techno Co. Ltd, Japan 
Binocular Microscope Olympus, Japan 
Trinuclear Microscope Olympus, Japan 
Freezer - 20ºC  LG, Korea 
Freezer -70ºC Napco, Czech Republic 
Documentation System: Vision SCIE-Plas Ltd, UK 
Safety Cabinet Heraeus, Germany 
Automated Karyotyping System Applied Spectral Imaging LTD, USA 
Computer System DELL, USA 
Spectrophotometer NanoDrop, USA 
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3.2.5. PCR oligonucleotide primers 
       All STSs PCR primers (indicated from 5`→ 3`) adopted in this study are 
shown in Table 3.4. Sense primers end with F (for forward), while antisense 
end with R (for reverse). All primer sequences were obtained from published 
literature. 
 
Table 3.4. Sequences of the different primer sets adopted in the present study 





ZFY-F ACCRCTGTACTGACTGTGATTACAC 495  Simoni et al., 2004 
ZFY-R GCACYTCTTTGGTATCYGAGAAAGT    
SRY-F GAATATTCCCGCTCTCCGGA 472 G38356 Simoni et al., 2004 
SRY-R GCTGGTGCTCCATTCTTGAG    
sY746-F TTGACTGCTTATTCTACACAAGGC 216 G49213 Sun et al., 2000 
sY746-R CAGGGGAAATTGGGTTTT    
sY84-F AGAAGGGTCTGAAAGCAGGT 326 G12019 Simoni et al., 2004 
sY84-R GCCTACTACCTGGAGGCTTC    
sY86-F GTGACACAGACTATGCTTC 320 G49207 Simoni et al., 2004 
sY86-R ACACACAGAGGGACAACCCT    
DBY1-F TATTGGCAATCGTGAAAGAC 277 G49468 Foresta et al., 2000 
DBY1-R TGCCGGTTGCCTCTACTGGT    
sY117-F GTTGGTTCCATGCTCCATAC 261 G11996 Ferlin et al., 2003 
sY117-R CAGGGAGAGAGCCTTTTACC    
sY125-F GGGATAGGGAAAGGGTACAA 200 G66531 Vollrath et al., 1992 
sY125-R CCGGGAGAAAAAAAACTGAA    
sY127-F GGCTCACAAACGAAAAGAAA 274 G11998 Simoni et al., 2004 
sY127-R CTGCAGGCAGTAATAAGGGA    
sY131-F ACATATCCCTTGCCACTTCA 143 G75620 Vollrath et al., 1992 
sY131-R TCAGGTACCTTCTGCCTGAG    
sY134-F GTCTGCCTCACCATAAAACG 301 G12001 Simoni et al., 2004 
sY134-R ACCACTGCCAAAACTTTCAA    
sY152-F AAGACAGTCTGCCATGTTTCA 125 G75623 Vollrath et al., 1992 
sY152-R ACAGGAGGGTACTTAGCAGT    
sY254-F GGGTGTTACCAGAAGGCAAA 380 G38349 Simoni et al., 2004 
sY254-R GAACCGTATCTACCAAAGCAGC    
sY255-F GTTACAGGATTCGGCGTGAT 123 G65827 Simoni et al., 2004 
sY255-R CTCGTCATGTGCAGCCAC    
sY272-F GGTGAGTCAAATTAGTCAATGTCC  95 G65830  Reijo et al., 1995  
sY272-R CCTTACCACAGGACAGAGGG    
sY1191-F CCAGACGTTCTACCCTTTCG 385 G73809 Repping et al., 2002 
sY1191-R GAGCCGAGATCCAGTTACCA    
sY1291-F TAAAAGGCAGAACTGCCAGG 527 G72340 Repping et al., 2002 




3.3.1. Blood collection 
       Approximately 5 ml venous blood were collected from each patient, and 
divided into two tubes, one containing sodium heparin for the cytogenetic 
testing, and the other contains EDTA for the molecular testing. 
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3.3.2. Cytogenetics/ GTG karyotyping 
       GTG karyotyping was performed by culturing patient's peripheral blood 
lymphocytes, from heparinized blood,  in ready made RPMI 1640 complete 
aqueous culture media (Biological Industries, Israel) containing the mitogen 
phytohemagglutinin (PHA), L-glutamine, antibiotics (Penicillin and 
Streptomycin), and fetal calf serum; and according to the following procedure: 
• Half milliliter heparinized blood was added to 5 ml of RPMI 1640 full 
medium in sterilized 15 ml falcon tube, mixed by inversion and 
incubated for 72 hours at 37ºC, 5% CO2 in CO2 incubator. 
• After 72 hours, 100 µl Colcemid (10 µg/ml) was added and mixed well 
with subsequent incubation for 30 minutes at 37ºC. 
• The cell culture tube was then centrifuged at 1200 rpm for 10 minutes 
and the supernatant was discarded leaving about 0.5 ml of supernatant 
remaining above cell pellet. 
• Cell pellet was resuspended in the remaining medium and 8 ml of 
prewarmed 0.075 M KCl was added with continuous gentle agitation to 
ensure proper mixing. 
• The cell culture tube was then incubated for 10 minutes at 37ºC in the 
incubator. 
• Cells were collected by centrifugation as above described.  
• Cells were then fixed by adding 10 ml of freshly prepared fixative (1 
part glacial acetic acid with 3 parts absolute methanol), with gentle 
agitation with subsequent incubation for 10-15 minutes at room 
temperature. 
• The cells were collected by centrifugation as above described. 
• The fixation step was repeated for at least two extra times to ensure 
proper fixation and removal of debris. 
• After the last centrifugation, the cells were resuspended in a small 
amount of fixative. 
• One to two drops of fixed cell suspension were applied from a height to 
the center of a pre-cleaned standard size glass slide. 
• The slides were then incubated at 56ºC in an oven for at least 2 days 
(extra baking time will usually give better results). 
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• The slides were then treated with 0.025% trypsin dissolved in Hank's 
balanced salt solution for 8-20 seconds. 
• The trypsinized slides were then stained in 1.5% Leishman stain for 3-5 
minutes and left to dry at RT. 
• The slides were then examined under the microscope, and checked for 
chromosome bands. 
• Good metaphase spreads were captured by the CCD camera, and 
were analyzed with the aid of Spectral Imaging software. 
       At least 20 metaphases (400-550 bands per genome) were analyzed for 
each patient, and 5 metaphases were karyotyped aided by the computerized 
imaging system (Applied Spectral Imaging LTD, USA). Karyotyping was 
performed by following the guidelines set by the International System for 
Human Cytogenetic Nomenclature (ISCN, 1995). In case of mosaicism the 
number of metaphases was increased to a total of 100 per analysis. 
 
3.3.3. Extracting and purifying genomic DNA 
       Genomic DNA from patient and control EDTA blood samples was 
extracted and purified by using Wizard® Genomic DNA Purification Kit 
(Promega, Madison, WI, USA), and adhering to the manufacturer protocol, 
which can be summarized as follows: 
1- Three hundred µl of well mixed blood were added to 1.5 ml Microfuge 
tube containing 900µl of cell lyses solution (lyses both red blood cells 
and white blood cells), mixed gently by inversion, and the lysate was 
incubated at room temperature for 10 minutes. During the incubation 
period, the tube was periodically mixed (2-3 times) by gentle inversion. 
2- The mixture was then centrifuged at 13,000 rpm for 20 seconds, and 
the supernatant was removed and discarded without disrupting the 
visible white pellet, then the white pellet was resuspended by vigorous 
vortexing (10-15 seconds). 
3- Three-hundred µl nuclei lyses solution, which lyses the nuclear 
membrane of white blood cell nuclei, were added to the resuspended 
pellet with pipetting the solution 5-6 times. The solution by now should 
become very viscous; the samples with visible clumps should be 
incubated at 37ºC until the clumps are disrupted. 
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4- One-hundred protein precipitation solution, which precipitates nuclear 
and cytoplasmic proteins, were added to the nuclear lysate and they 
were mixed vigorously for 10-20 seconds by the vortex, then 
centrifuging at 13,000 rpm for 3 minutes at room temperature. A dark 
brown protein pellet should be visible. 
5- The supernatant was then transferred to a clean 1.5 ml Microfuge tube 
containing 300µl isopropanol and was mixed gently by inversion until 
white thread-like strands of DNA form a visible mass, then centrifuged 
at 13,000 rpm for 1 minute. The DNA will be visible as a small white 
pellet. 
6- The supernatant was discarded and 300 µl of 70% ethanol were added 
to the small white pellet and gently inverted several times to wash the 
DNA pellet, then centrifuged at 13,000 rpm for 1 minute. 
7- The ethanol was aspirated carefully, and then the tube was inverted on 
clean gauze. The pellet was air-dried for 10-15 minutes. 
8- The DNA pellet was rehydrated by adding 100µl DNA rehydration 
solution and incubated at 65ºC for one hour. The DNA pellet should be 
mixed periodically by gently tapping the tube. 
9- Finally, the DNA was stored at 2-8ºC until PCR analysis is carried out. 
10- The quality of the extracted DNA was monitored on ethidium bromide 
stained 2% agarose gels and the quantity of DNA (1 OD at 260 nm ~50 
µg/ml) was measured by spectrophotometer (Nanodrop, USA) at 260 
nm. 
 
3.3.4. Molecular analysis 
 
3.3.4.1. Primers (STSs) 
       Microdeletion analysis of the Y chromosome Yq AZF region involved two 
steps. In the first step, aimed at detecting AZFa, AZFb and AZFc complete 
microdeletions, a total of 13 previously published STSs (AZF loci) that are 
mapped at intervals 5 and 6 on the long arm of the Y chromosome were used 
(Fig.3.1); sY746, sY84, sY86, and DBY1 for AZFa, sY117, sY125, sY127, 
sY131, and sY134 for AZFb, and sY152, sY272, sY254, and sY255 for AZFc. 
STSs shown in bold are all those recommended by the European Academy of 
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Andrology/European Molecular Genetics Quality Network (EAA/EMQN) 
guidelines, which suppose to detect over 90% of Y chromosome 
microdeletions, the other STSs are supplementary and were used to increase 
microdeletion detection rate. In addition, SRY (sex determination region of Y) 
gene and the X/Y homologous gene pair Zinc-Finger X (ZFX) and Zinc-Finger 
Y (ZFY) primers were designed to be used as positive internal controls to 
detect amplification failures in case a microdeletion was detected. The 
sequences of all primer pairs and the expected size of their products are 




        
                                     
 
Figure 3.1. Relative physical positions of the STSs adopted in the study. 
       In the second step, when step one does not show any AZF deletion for 
any patient, we looked for AZFc partial deletions using sY1291, and sY1191 
primer sets. The physical position of these STSs within the AZFc region is 
shown in Figure 3.2. The sequences of both primer pairs and their expected 







Figure 3.2. Physical positions of the adopted STSs that detect partial AZFc deletions. 
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3.3.4.2. Controls for microdeletions 
       Positive and negative controls were run concurrently with each patient 
sample. Female and proven fertile male DNA samples were used as negative 
and positive controls, respectively.  Water instead of genomic DNA was used 
as blank to check for any DNA contamination. 
3.3.4.3. Yq microdeletion analysis by PCR-based STS  
       PCR was carried out in a monoplex (single primer set, simplex) fashion 
for each primer set. PCR was carried out in 0.2 ml PCR Microfuge tubes in a 
20 µl reaction volume containing: 2 µl template genomic DNA (100-200 ng), 
10 µl PCR Master mix or Go Taq® Green Master Mix (Promega Madison, WI, 
USA), 1.5 µl (2 µmol) each primer, and nuclease free sterile distilled water to 
20 µl. The amplification reaction was performed in a programmable thermal 
cycler. Amplification was started with an initial denaturation step at 94ºC for 
15 minutes, followed by 35 sequential cycles each including 60 seconds 
denaturation at 94ºC, 60 seconds primer annealing at 57ºC and 60 seconds 
extension at 72ºC. The protocol was followed by a final extension step at 72ºC 
for 10 minutes and then cooling to 4ºC to be ready for electrophoretic 
detection.  
       For detecting AZFc partial deletions, we used the same reaction mixture 
and volume as above, but instead using different primer sets. The following 
PCR protocol was employed: 5 minutes initial denaturation (94ºC), followed by 
35 sequential cycles of 30 seconds denaturation (94ºC), 45 seconds primer 
annealing (61ºC), and 45 seconds extension (72ºC), ended by an extension 
step of 7 minutes at 72ºC and then cooling to 4ºC to be ready for 
electrophoretic detection. 
       With a PCR product of the expected size, the reaction was regarded as 
positive for this STS. Negative PCR products (no amplification) of the same 
STS in 3 consecutive independent attempts were interpreted as deletions for 
this STS.  
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3.3.4.4. PCR products electrophoretic detection 
       The PCR yield product was added to the loading dye, mixed and run on a 
2% (w/v) agarose gel containing 0.5 µg/ml ethidium bromide in 1x Tris Acetate 
EDTA (TAE). In addition, a 100 bp DNA ladder was always run concurrently 
with each electrophoretic run to detect product sizes. After electrophoresis at 
70 volts for 45 minutes, the results were visualized and documented using the 
UV transilluminator documentation system (Vision, Scie-Plas Ltd, UK). 
3.4. Statistical analysis 
       In general, parametric statistics were used. Comparisons of qualitative 
data were carried out by means of Chi-square test (χ2) in 2X2 contingency 
tables. While quantitative data were handled by means of unpaired Student's 
t-test for independent samples. Statistical analysis was performed using the 
statistical package SPSS for windows (version 12, SPSS Inc., Chicago, IL, 
USA) and Minitab version 14.12 statistical software. A P value of less than 





















4.1. Patient data analysis 
       The general features and findings of our patient population are 
summarized in Table 4.1. 
 
 
Table 4.1. General features and findings in the studied 
population 
No. of patients (n) 85 
Age (yrs) 30.49 ± 6.43 (18-52)a 
Height (cm) 175.12 ± 7.25 (156-198) 
Weight (kg) 78.65 ± 12.18 (58-115) 
Duration of infertility (yrs) 6.3 ± 5.2 (0.0-29)b 
Seminal fluid volume (ml) 3.0 ± 1.0 (1.0-5.2) 
Patients with history of:  
Infertility  16 (18.8%)c 






a Mean ± SD (range) 




4.2. Spermatogenic potential 
       Based on sperm count, our patient population was classified into four 
subgroups: azoospermic (59, 69.4%), cryptozoospermic (3, 3.5%), severe 
oligozoospermic (17, 20%), and oligozoospermic (6, 7.1%), Table 4.2. 
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Table 4.2. Classification of patients according to their sperm counts 
Sperm count category # Patients Sperm count range M/ml  % 
Azoospermic 59 0.0 69.4 
Cryptozoospermic 3 0.03-0.1 3.5 
Severe Oligozoospermic 17 0.2-4.2 20 
Oligozoospermic 6 6.0-10.0 7.1 
 
4.3. Hormonal parameters data 
       Hormonal profile (FSH, LH, total testosterone, prolactin, and Inhibin B) 
data was not available for all patients, nor was complete hormone profile 
available for all patients. Serum FSH level was available for 79 patients, 
serum LH level was available for 72 patients, total testosterone level was 
available for 75 patients, prolactin level was available for 71 patients, while 
Inhibin B level was only available for 29 patients (25 azoospermics and 4 
severely oligozoospermics). Table 4.3 summarizes the available hormonal 
data for the patient population. Table 4.4 summarizes the mean available 
hormonal values for each spermatogenic potential subgroup. 
 
 
Table 4.3. Summary of the available hormonal values in entire patient population 
Hormone # of patients Mean ± SD (range) 
FSH (mIU/ml) 79 16.96 ± 11.35 (0.0-43.0)a 
LH (mIU/ml) 72 10.55 ± 6.62 (0.0-31.6) 
Total Testosterone (ng/ml) 75 3.9 ± 1.61 (0.5-8.9) 
Prolactin (ng/ml) 71 12.6 ± 5.47 (2.2-24.0) 
Inhibin B (pg/ml) 29 55.3 ± 28.43 (17.3-160) 
 
Table 4.4. Mean hormone profile values for each spermatogenic potential subgroup 
Mean (range)     
Azoospermics Cryptospermics Severely Oligospermics Oligospermics 
FSH 19.5 (0-43) 26.5 (22-31) 9.2 (2.2-26) 7.8 (4.5-12.4) 
LH 10.5 (0-31.6) 15.3 (9-21) 10.8 (5.9-19.7) 8.7 (1.6-16.3) 
Total Testosterone 3.8 (0.5-8.9) 3.4 (3-3.8) 4.2 (2.2-6.8) 4.1 (2.2-5.7) 
Prolactin 12.1(2.2-24) 18.7 (n=1) 13.6 (4.9-21.6) 14.9 (8-20.8) 
Inhibin B 52.1 (17.3-120) 21 (n=1) 82.9 (42-160) NDa 
a ND: No data available 
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Table 4.5. Hormonal t-test P values when comparing azoospermics with the other 
spermatogenic potential subgroups 
Hormone Cryptozoospermics Severely oligozoospermics Oligozoospermics 
FSH 0.401   0.002 a   0.017 a 
LH 0.355 0.894 0.537 
Testosterone 0.743 0.484 0.734 
Prolactin 0.230 0.408 0.225 
Inhibin B 0.144   0.041 a - 
       a Tagged P values indicate statistical significance (P<0.05) 
 
       As can be noted from Table 4.5, there is a statistically significant 
difference in FSH values between azoospermics and severely 
oligozoospermics (P=0.002), as well as between azoospermics and 
oligozoospermics (P=0.017). FSH values in azoospermics were higher than 
the other spermatogenic potential subgroups, except cryptozoospermics (P= 
0.401). In addition, Inhibin values in azoospermics were lower than severely 
oligozoospermics (P=0.041), however it should be noted that only 4 severely 
oligozoospermic patients did the Inhibin B quantitation. While, there was no 
statistical significant difference in LH, total testosterone, or prolactin between 
the azoospermics and the different spermatogenic potential subgroups. We 
can observe that the FSH levels are in direct relationship with degree of 
spermatogenic failure. 
 
4.4. Testicular histology  
       Only 46 testicular biopsy histological reports were available for the 
studied population. Forty-two reports were available for the azoospermic 
patient group, three for the cryptozoospermic patient group (cases# 52, 56, 
and 77), while only one (case# 60; sperm count 0.6 M/ml) for the severe 
oligozoospermic patient group. No reports were available for any patient in the 
oligozoospermic patient group. 
       Table 4.6 summarizes the results of these reports into Sertoli cell-only 
(SCO), spermatogenesis arrest (SGA) (although different patients show 
spermatogenic arrest at different stages of spermatogenesis, with no 
spermatozoa, but we collectively referred to them as SGA), and 
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hypospermatogenesis (HS). We observed the absence of SCO picture in the 
cryptozoospermic or severe oligozoospermic patients. 
 
Table 4.6. Summary of results for the available testicular histology reports 
Diagnosis Total Azoospermics Cryptozoospermics Severe Oligozoospermics 
SCO 7 7 0 0 
SGA 26 25 1 0 
HS 13 10 2 1 
Total 46 42 3 1 
 
       SCO patients have significantly higher FSH values than SGA patients 
(P=0.00), while LH, total testosterone, prolactin, and Inhibin B did not show 
any statistical significant difference (P= 0.065, 0.083, 0.257, 0.268, 
respectively) [data not shown]. No statistically significant difference was found 
between SCO and HS patients regarding FSH, LH, total testosterone, 
prolactin or Inhibin B (P=0.05, 0.804, 0.245, 0.423, respectively) [data not 
shown]. In addition, all hormones did not show any statistical significant 
difference in their values when HS and SGA patients were compared (data 
not shown). Consequently, hormonal levels cannot predict the histology of 
testicular biopsies. 
 
4.5. Cytogenetic analysis by GTG banding 
       Among the 85 infertile men studied, 8 patients showed abnormal 
chromosomal karyotypes corresponding to a prevalence of 9.4%, the results 
of cytogenetic analysis is shown in Table 4.7. The occurrence of 
chromosomal abnormalities was only confined to the azoospermic patient 
group. Patients with abnormal karyotypes represented 13.6% of the 
azoospermic patients. Four had a 47, XXY karyotype (Cases# 9, 27, 59, and 
74), correspondent to Klinefelter's syndrome, and represented 4.7% of the 
patient study population, 50% of the chromosomal abnormalities patient group, 
and 6.8% of the azoospermic patient group (Fig. 4.1.). One patient (case# 46) 
had 47,XY, +mar karyotype, and represented 1.18% of the patient study 
population, 12.5% of the chromosomal abnormalities patient group, and 1.7% 
of the azoospermic patient group (Fig. 4.2). One patient (case# 64) had 
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46,XY, del 17(q25) karyotype, and represented 1.18% of the patient study 
population, 12.5% of the chromosomal abnormalities patient group, and 1.7% 
of the azoospermic patient group (Fig. 4.3.). One patient (case# 69) had a 
chromosomal instability with a heterogeneous scale of mosaic aneuploides, 
(Fig. 4.4-4.6.). One patient (case# 86) had Robertsonian fusion between 
chromosomes 15 and 21 [45,XY, -15,-21,+Robertsonian Fusion (15;21) 





Table 4.7. Abnormal cytogenetic results among patient population 
Case # Karyotype Sperm count Testicular 
Pathology 
9 47,XXY Azoospermia SCO 
27 47,XXY Azoospermia SCO 
46 47,XY,+mar Azoospermia ND* 
59 47,XXY Azoospermia SCO 
64 46,XY,del17(q25) Azoospermia SGA 
69 Chromosomal instability (multiple karyotypes) Azoospermia ND 
74 47,XXY Azoospermia SGA 
86 45,XY, -15,-21,+Robertsonian Fusion (15;21)  Azoospermia ND 
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Figure 4.6. Hyperdiploid cell karyotype: 49,XY,+1,-2,+3,-4,+7,+11,+13, -14, +15, +18, -22 










Figure 4.7. Robertsonian fusion (15;21) obtained from 7 different metaphases  
                   (case# 86) 
 
 
4.5.1 Klinefelter's syndrome patients 
 
       Patients with Klinefelter's syndrome (KFS) diagnosed in our study (n=4) 
all showed elevated FSH and LH concentrations and ranged from 27.0 to 43.0 
(normal range 2-10 mIU/ml) and 16.8 to 31.6 (normal range 1.0-13.8 mIU/ml), 
respectively. Serum testosterone values ranged from 1.6 to 2.4 (normal range 
2-7 ng/ml) were all either below the normal range or in the low normal range. 
All of our patients were azoospermics, and all had small testes. 
       Our Klinefelter syndrome patient series showed significantly higher FSH 
and LH values than the other azoospermic patients (P=0.005, and 0.00 
respectively). Their heights also were significantly higher than the other 
azoospermic patients (P=0.004) as well as the entire patient population 
(P=0.001). While serum testosterone levels and semen volumes were 
significantly lower than the other azoospermic patients (P= 0.028 and 0.005, 
respectively) or the entire population (P=0.001 and 0.005, respectively). Table 
4.8 shows all of the aforementioned P values. It was also observed that none 
of our patients had a history of neither varicocele nor cryptorchidism. All 
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Table 4.8. Comparisons between KFS patients and different spermatogenic potential subgroups 
Group FSH LH Testc PRLd Height Weight Volumee 
Entire population a 0.001b 0.0b 0.014b 0.752 0.001b 0.172 0.005b 
Azoospermics 0.005b 0.0b 0.028b 0.916 0.004b 0.179 0.005b 
Cryptozoospermics 0.215 0.184 0.017b 0.29 0.161 0.284 0.188 
Severe Oligozoospermics 0.00b 0.00b 0.003b 0.602 0.004b 0.151 0.005b 
Oligozoospermics 0.00b 0.002b 0.014b 0.334 0.015b 0.601 0.080b 
a Excluding Klinefelter's patients;  
b Tagged P values indicate statistical significance (P<0.05) 
c Total Testosterone 
d Prolactin 
e Semen volume 
 
 
4.6. AZF classical microdeletions 
       No Y chromosome classical microdeletions in AZFa, AZFb or AZFc could 
be detected among the 85 infertile men included in this study. An example of 
the STSs adopted to detect classical microdeletions and their product sizes 






Figure 4.8. A and B are examples of ethidium bromide stained agarose gels for 
detecting classical AZF deletions and the STSs and their product sizes adopted in the 
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4.7. Distribution of partial AZFc deletions in patients and  
       proven fertile controls  
       In order to detect partial AZFc deletions our goal was to detect the unique 
fragments flanking the DAZ1/DAZ2 doublet at the u3 segment (proximal) and 
the P2/P1 palindrome junction (distal), corresponding, respectively, to sY1191 
and sY1291 used in previous studies (Repping et al., 2003; Fernandes et al., 
2003; Machev et al., 2004). We relied on sY1191 and sY1291 STSs to 
discriminate between the different AZFc partial deletion patterns, by applying 
the results shown in Table 4.9. 
 
Table 4.9. +/- STS PCR AZFc partial deletion classification scheme 
AZFc partial deletion pattern sY1291 sY1191 
No deletion + + 
gr/gr - + 
b2/b3 + - 
b1/b3 - - 
              (+)= No deletion; (-)= deletion 
 
       In total, seven (8.2%) out of the 85 infertile men investigated had partial 
deletions within the AZFc region. In particular, we found two different patterns 
of partial AZFc deletions; the gr/gr (6/85, 7%) and the b1/b3 (1/85, 1.2%) 
deletions, whereas b2/b3 was absent in our patient group. One man with gr/gr 
deletion was oligozoospermic (case# 57, sperm count 6.4 M/ml), one was 
severely oligozoospermic (case# 79, sperm count 0.7 M/ml), but the others 
were azoospermics, while the patient with b1/b3 deletion was severely 
oligozoospermic (case# 71, sperm count 2.6 M/ml). Testicular biopsy reports 
were available only for three of the seven patients with partial deletions of the 
AZFc region. One patient (case# 17) had Sertoli cell-only syndrome (SCOS), 
one patient (case# 47) had spermatogenic arrest and one patient (case# 64) 
had severe hypospermatogenesis. One subject (1/30, 3.3%) in the control 
fertile group proved to have gr/gr deletion, which was the only pattern of 
partial deletions of the AZFc region observed in the control group. The 
summary of all deletions and their distribution in the different groups of 
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spermatogenic failure are given in Table 4.10. The clinical data of the deleted 
subjects in the infertile group are shown in Table 4.11. The sY1291 and 
sY1191 STS PCR results for some patients with partial AZFc deletions are 




Table 4.10. Frequencies of partial AZFc deletions in the study population 
and the control groups 
 Deletion Pattern Group 
n gr/gr; n(%) b2/b3; n(%) b1/b3; n(%) Total; n(%) 
Infertile 85 6 (7.0%) None 1 (1.2%) 7 (8.2%) 






Table 4.11. Clinical data of subjects with partial AZFc deletions 
















17 gr/gr Azo SCO 19.3 8.2 5.7 8.6 36 
47 gr/gr Azo SGA 7.5 8.0 5.0 17.0 NA¥ 
49 gr/gr Azo ND 12.0 5.3 2.8 15.0 NA 
57 gr/gr Oligo ND 4.5 13.2 4.7 16.1 NA 
64 gr/gr Azo HS 2.4 NA 1.4 NA NA 
71 b1/b3 S Oligo ND NA NA NA NA NA 
79 gr/gr S Oligo ND 6.1 9.2 5.2 20.4 NA 
¶ Azo= Azoospermia, Oligo= Oligozoospermia, S Oligo= Severe oligozoospermia  
§ SCO= Sertoli cell-only, SGA= Spermatogenic arrest, HS= Hypospermatogenesis, ND= Not done 









Figure 4.9. Ethidium bromide stained agarose gels for some of our gr/gr deleted cases. 
A: sY1291 STS PCR reactions demonstrating absence of sY1291 (527 bp) in gr/gr 
deletion cases #17, 47, 49, and 57 (lanes 4-7, respectively). B: sY1191 STS PCR 
reactions showing presence of sY1191 (385 bp) in the same aforementioned gr/gr 
deleted cases (lanes 4 to 7 respectively). L= 100 bp DNA ladder, Lane 1: negative 
control (water), Lane 2: negative control (normal female genomic DNA), Lane 3: 
positive control (normal proven fertile male genomic DNA).  
 
Figure 4.10. Ethidium bromide stained agarose gel electrophoresis for case# 71 that 
harbors b1/b3 partial AZFc deletion. L: 100 bp DNA Ladder, Lane1: sY1191 negative 
control (normal female genomic DNA), Lane2: sY1191 positive control (normal proven 
fertile male genomic DNA), Lane3: sY1291 negative control (normal female DNA), Lane 
4: sY1291 positive control (normal proven fertile male DNA), Lane 5: sY1191 for case# 
71, Lane 6: sY1291 for case# 71. Both sY1191 and sY1291 are absent in case# 71 and 
this characterizes b1/b3 partial AZFc deletion according to the +/- partial AZFc 
classification scheme. 
 
       The gr/gr deletion was found in both the infertile and the proven fertility 
control populations. The deletion frequency of gr/gr in the infertile group was 
7.0%, while it was 3.3% in the control proven fertile group. No statistically 
significant difference in deletion frequency was found between the two 
populations (χ2= 0.54, P= 0.764,).  
 
                                                                                                                                         Results 
 64
       The deletion frequency of b1/b3 in the infertile group was 1.2%, while it 
was 0.0% in the proven fertility control group. The difference in deletion 
frequency between the two populations was not statistically significant (χ2= 
0.356, χ2 critical=3.84, α = .05). 
       In addition, no statistically significant difference in partial AZFc deletion 
frequency was found between the infertile and the proven fertility control 
populations (χ2= 0.8233, P=0.663). 
       No statistically significant difference was found between the partially 
deleted AZFc patients and the nondeleted infertile patients in levels of FSH 
(P=0.061), LH (P=0.54), total testosterone (P=0.585), prolactin (P=0.239), or 
Inhibin B (P=0.5), as well as in height (P=0.753), weight (P=0.618), and 
seminal fluid volume (P=0.087).  Consequently, hormonal data are not useful 
in predicting cases with lone absence of sY1291. 
       No family history of infertility was noted for all AZFc partially deleted 
patients, except one (case# 79, sperm count 0.7 M/ml) in which his brother 
also suffers from severe oligozoospermia (sperm count 0.4 M/ml) that was 
tested for partial AZFc deletions, and his Y chromosome was also found to 
harbor gr/gr deletion, see Figure 4.11 lane 11. Moreover, his uncle (from his 
mother side) suffers from infertility (no data available, but he is infertile 
according to the WHO definition), suggesting that his infertility is inherited and 
it is most probably related to the autosomes or the X chromosome, but not to 
the Y chromosome. 
 
 4.7.1. Source of AZFc partial deletions 
       In all instances in which DNA samples from the father (case# 17), or the 
brothers (cases# 49, 64, 79) of an infertile gr/gr deletion subject were 
available for testing, we found that the father's and brothers Y chromosomes 
also had gr/gr deletion, provided that all of the brothers are married and all 
had at least naturally conceived one child, except case# 79 (see above), 
Figure 4.11. No relatives were available for testing the source of the b1/b3 
partial deletion found in Case# 71.  
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Figure 4.11. Ethidium bromide stained agarose gel electrophoresis for determining the 
source of the gr/gr deletion pattern in our patients. L: 100 bp DNA Ladder, Lane 2: 
negative control (normal female genomic DNA), Lane 3= positive control (proven fertile 
male genomic DNA), Lane 4: case #17, Lane 5: father of case# 17, Lane 6: case# 49, 
Lane 7: brother of case# 49, Lane 8: case# 64, Lane 9: brother of case# 64, Lane 10: 















5.1. Cytogenetic analysis by GTG Karyotyping 
       In the present study, both numerical and structural chromosomal 
aberrations were found in our patient study population. The occurrence of the 
chromosomal abnormalities was only confined to the azoospermic patient 
group; this could be the effect of the small size and slightly unbalanced nature 
of our patient study population (azoospermics 59, severely oligozoospermics 
17, and oligozoospermics 6). The prevalence of chromosomal anomalies 
among the studied infertile men was found to be 9.4%. This figure lies within 
the previously published range (3.6-22.6%), as shown in Table 5.1. 
Association between human male infertility and chromosomal anomalies has 
been known for a long time (Chandley A, 1979; Faed et al., 1979). 
Chromosomal abnormalities are more frequently observed in the population of 
azoo/oligozoospermic males than in the general population (Tuerlings et al., 
1998). Thus, it would not be unusual to find chromosomal abnormalities in 
men attending infertility clinics.  
  
Table 5.1. Literature reporting chromosomal abnormalities in infertile men 
Source Study subjects (n) Chromosomal abnormalities (%) 
Kondoh et al., 1992 130 13.8 
Pandiyan and M-Jequier, 1996 1210 3.6 
Gündüz et al., 1998 102 15.7 
Kleiman et al., 1999 72 16.6 
Penna Videaú et al.,2001 84 22.6 
Nagavenker et al., 2005 88 10.2 
Pina-Neto et al., 2006 165 9.6 
Hellani et al., 2006 257 3.9 
Mohammed et al., 2007 289 8.0 
This study, 2007 85 9.4 
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       The distribution of chromosomal abnormalities detected in the present 
study showed that Klinefelter's syndrome (47,XXY) was the most prevalent 
abnormality, representing 50% (4/8) of our positive cases. This result was in 
agreement with several previously published studies (Guichaoua et al., 1993; 
Pandiyan and M-Jequier, 1996; Nakamura et al., 2001; Penna Videaú et al., 
2001; Rao et al., 2004; Lissitsines et al., 2006; Pina-Neto et al., 2006; 
Mohammed et al., 2007). Our result was not unexpected since Klinefelter's 
syndrome was described as the most frequent genetic cause of male infertility 
(Lanfranco et al., 2004; Simoni et al., 2004).  
       All KFS patients have SCO testicular biopsy, except one who showed 
SGA biopsy result; this is not unexpected result since there are several 
reports in which Klinefelter's syndrome patients have fathered biologically 
although only by assisted reproduction techniques (Tournaye et al., 1996; 
Bergere et al., 2002). This proves that not all Klinefelter's syndrome patients 
deem to be a homogenous group. Therefore, testicular biopsies and/or TESE 
should be warranted for all Klinefelter's syndrome patients. The specific 
combination of azoospermia, very high FSH and LH, small testes, tall stature, 
low or low normal testosterone and reduced semen volume may predict the 
XXY phenotype. 
       The exact mechanism by which chromosomal anomalies induce infertility 
is not clear. It is likely that the presence of abnormally distributed chromatin 
may interfere with meiotic division, therefore, reduces sperm production 
(Yamamoto et al., 2002). Testicular histology in such patients may reveal 
areas of atrophy and hyalinization of the seminiferous tubules as well as some 
areas with tubules of normal appearance that contain a reduced number of 
mature spermatozoa (Yamamoto et al., 2002; Wikstrom et al., 2004). 
Spermatozoa bearing abnormal chromosomes may cause abnormal 
embryonic development that can in turn cause early pregnancy loss (Evans et 
al., 1978). Moreover, these chromosomal aberrations may have serious 
implications for infertile males who seek the help of intra-cytoplasmic sperm 
injection (ICSI) due to the possibility of transmission of these abnormalities to 
the offspring (Reubinoff et al., 1998; Ron-el et al., 1999; Bonduelle et al., 
2005). 
                                                                                                                                    Discussion 
 68
       To conclude, chromosomal abnormalities found with relatively high 
prevalence in our infertile males are the major cause of their male infertility, 
and justify the requirement of cytogenetic analysis for every infertile male, 
particularly azoospermics, seeking children. 
 
5.2. Y-chromosome classical microdeletions 
       The present study shows absence of AZF microdeletions in the long arm 
of the Y chromosome in the studied infertile population. This is in agreement 
with some previously published studies. Tzschach et al. (2001) reported the 
absence of such structural abnormality in 97 infertile men, Gruber et al. (2003) 
in 383 infertile men, and Bush et al. (2004) in 96 infertile men. Moreover, very 
low prevalence of Y chromosome microdeletions was reported in other 
studies. Bor et al. (2002) reported a prevalence of 0.75% of Y chromosome 
microdeletion in 400 infertile men, Medica et al. (2005) found Y chromosome 
microdeletions in 0.95% of 105 infertile males and Van der Ven et al. (1997) 
found Y chromosome microdeletion in 0.98% of 204 infertile.  
       Nap et al. (1999) reported deletions in 2.3% of 1627 infertile men who 
were seen in 14 infertility centers in the Netherlands and Belgium, and Ferlin 
et al. (2007) in a prospective study that extended for 10 years (from January 
1996 to December 2005) reported a total incidence of 3.2% in 3073 infertile 
men. However, the same authors in 1998 reported the highest proportion of 
microdeletions published so far, they reported an incidence of 55% among a 
highly selected group of 18 patients with histologically confirmed Sertoli cell-
only syndrome (SCOS). More intriguing, Kihaile et al. (2005) studied the 
occurrence of Y chromosomal microdeletions in two different populations, 
Japanese and Africans. They found Y chromosome microdeletion prevalence 
of 6.2% in Japanese, but absence of Y chromosome microdeletions in 
Africans. This may highlight the association of Y chromosomal microdeletions 
with certain Y chromosome haplogroups. Some Y haplogroups are more 
susceptible to deletions than others, while other Y chromosome haplogroups 
may confer protection against microdeletions. For example, Y chromosome 
haplogroup J seems to protect against AZFa deletions because they lack the 
LIPA4 element in HERV15q2 which is supposed to facilitate the homologous 
intrachromosomal recombination leading to AZFa deletion as described by 
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Ferlin et al. (2007). Moreover, same investigators also observed a reduction 
of the J haplogroup frequency in their AZFc microdeleted samples. 
Noteworthy, Nebel et al., (2001) found a high proportion of Palestinians 
(55.2%), residing in Israel and the Palestinian Authority area to belong to this 
particular Y haplogroup. Furthermore, they also observed that Palestinians 
differ in there Y chromosome pool from Europeans and other Middle East 
populations included in their study.  
       It was postulated by Vogt (2005a) that the number of amplicons and 
palindromes in the AZFb and AZFc regions vary between different Y 
chromosome haplogroups. If this holds true, then we can safely assume that 
the number of amplicons and palindromes in the present studied Palestinian 
infertile males Y chromosome haplogroup(s) most likely differ or deviate from 
the established reference AZFb and AZFc structures that belong only to one 
donor (RP-11 donor), and thus to one Y chromosome haplogroup, i.e., R* Y 
haplogroup, which is not popular in our Middle East region. Noteworthy, this 
single donor fertility status is unknown. 
       During our extensive search in the literature concerning Y chromosome 
microdeletions, we found only five Arab studies. The first one was conducted 
in Egypt (El Awady et al., 2004), which is our direct neighbor country; they 
reported a frequency as high as 12% (4/33), two with AZFc deletion, one with 
AZFa deletion, and one with AZFa-b-c deletion. The two patients with AZFc 
deletion described in the study were found to be deleted only for a single STS 
(sY272) and not for the other AZFc STSs they used, and the authors 
suggested that this STS might be considered as a hot spot site for Y 
chromosome microdeletions in Egyptian population. If we take into account 
Pryor et al. (1997) findings regarding this particular STS in which they found 
deletion of this single STS in two normal males who have conceived children 
before as well as in one infertile male whose father also shows an absence of 
the same STS. This proves that this STS (sY272) is a polymorphic site and its 
absence can be regarded as a polymorphic loss and not as deletion. This will 
substantially reduce the frequency of microdeletions in the Egyptian study to 
6%. In addition, their small population size should also be taken into 
consideration, as each patient included in their study population represents 
3%. The second study was conducted among Saudis in Saudi Arabia (Hellani 
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et al., 2006) where the authors reported incidence was 3.2% (8/247). The 
authors concluded that Y chromosome microdeletions are low in Saudi 
population. The third study was Tunisian (Hadj-Kacem et al., 2006), which 
had shown a prevalence of 16% (26/163) in a group of patients who had 
sperm counts ranging from normospermia (65/163), oligozoospermia (53/163) 
to azoospermia (45/163). If we exclude the normospermics then the frequency 
will be raised to 26.5%, i.e., one out of 4 patients; moreover they stated that 
they detected a deletion, uncharacterized by the authors, in one 
normospermic infertile patient. It is noteworthy that they had used only 8 STSs 
to detect such deletions, and we believe that the results of this Tunisian paper 
are conflicting. The fourth study was conducted among Moroccan infertile 
men (Imken et al., 2007); the authors reported prevalence was 3.2% (4/127). 
The fifth study was a novel study that was conducted among Kuwaitis in 
Kuwait (Mohammed et al., 2007) where the authors reported a low AZF 
microdeletion prevalence of 2.4% (7/266). The low prevalence of 
microdeletions in both Kuwaitis (2.4%) and Saudis (3.2%) may reflect the 
common ethnic origin, as both are next-door neighbors.  
       To summarize, we suggest that the low prevalence of AZF classical 
deletions is influenced by ethnic factors, genetic background and Y 
chromosome haplogroups. Therefore, we strongly recommend conducting 
studies to analyze and then determine the distribution of Y-chromosome 
haplogroups in Gaza Strip population. Moreover, other genetic, epigenetic, 
nutritional and environmental factors may be responsible for the 
oligozoospermia and azoospermia cases observed in the Gazian Palestinian 
population.  
 
5.3. AZFc partial deletions 
       In the present study, we analyzed the occurrence of partial AZFc 
deletions in Gazian Palestinian infertile men and proven fertile controls. The 
commonest partial AZFc deletion pattern observed was the gr/gr pattern 
which was detected in six (6/85, 7%) patients and in only one (1/30, 3.3%) 
proven fertile control; there was no statistically significant difference between 
the two groups. This figure (7%) is slightly higher than the previous reported 
figures of about 5% in infertile men (Repping et al., 2003; de Llanos et al., 
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2005; Fernando et al., 2006). Nevertheless, small population sizes usually 
show higher frequencies. 
       In three gr/gr deleted patients, the origin of the deletion was confirmed to 
be inherited and not due to a de novo rearrangement, as their fertile relatives 
showed the same deletion pattern. The fourth available relative was the 
brother of case# 79, who showed the same deletion pattern as his brother, i.e. 
gr/gr deletion pattern, giving that he is severely oligozoospermic. This 
particular case may suggest that the Y chromosome is not responsible, since 
their uncle from mother side, no data available, is also infertile but according 
to the WHO definition. The successful transmission of gr/gr deletion pattern 
from generation to generation contraindicates a direct association of gr/gr 
deletion and spermatogenic failure. Our data show that gr/gr deletion 
represents a polymorphic event as it is found not only in patients suffering 
from spermatogenic failure but also in men with proven fertility. 
       As mentioned earlier, 55.2% of Palestinians belong to the J haplogroup 
as reported by Nebel et al. (2001). Machev et al. (2004) had described 
polymorphic loss of sY1291 locus in J haplogroup. gr/gr deletions are 
characterized by the deletion of either DAZ gene doublets, whereas 
polymorphic loss of sY1291 does not alter the DAZ copy number. Therefore, 
the absence of only sY1291 in not sufficient in confirming gr/gr deletion, for 
confirmation, we recommend the extension of this study using FISH, Southern 
blot, and quantitative DAZ copy assay.  
       Interestingly, both Lin et al. (2007) and Zhang et al. (2007) had described 
individuals who lack sY1291 amplified fragments but with 4 DAZ genes. 
These individuals where found to carry a Y chromosome variant with a gr/gr 
deletion followed by an additional compensatory duplication of b2/b4 AZFc 
region that restored the DAZ copy number. This del/dup AZFc model can be 
proved by the presence of only 2 kinds of DAZ instead of 4 kinds (as each 
DAZ differ in the RNA-binding motif copy number), or measuring DAZ copy 
number by quantitative DAZ copy assay.  
       In the present study, we found no case with complete AZFc deletion. 
Zhang et al. (2007) assumed that complete AZFc deletion in addition of being 
caused by a de novo complete deletion, it could be caused by a two step 
process, partial AZFc deletion followed by deletion of the entire AZFc region. 
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They also postulated that a high frequency of complete AZFc deletions in Y-
chromosomes harboring gr/gr deletion is expected. If this holds true, and if our 
cases are true gr/gr deletion cases, consequently, we will expect a high 
complete AZFc deletion frequency in our population, however, this was not 
the case! 
       Alternatively, we believe that our sY1291 deleted cases in the infertile as 
well as in the proven fertile groups are either due to the polymorphic loss of 
sY1291 locus representing untrue gr/gr deletions, or due to the initial gr/gr 
deletion followed by a compensatory partial duplication of the b2/b4 AZFc 
region, i.e., del/dup AZFc model, or both. Furthermore, Y haplogrouping 
should be defined on these cases to explore if a specific Y chromosome 
haplogroup have a fixed gr/gr deletion that have been descended from a 
deleted founder(s) or not. 
       The b1/b3 deletion pattern, a 1.6 Mb deletion size, was only observed in 
the infertile group, but because we could not detect more than one case 
(sperm count 2.6 M/ml) it was not sufficient to draw conclusions on its effect 
on spermatogenesis. In addition, due to the shortage of DNA for this particular 
case we couldn't do further characterization, but since it is characterized by 
the absence of both sY1191 and sY1291, which are apart, we would safely 
regard it as true (pathogenic) deletion, in appose of our sY1291 deleted cases.  
       As a conclusion, our results and observations are congruent with Machev 
et al. (2004), Hucklenbroich et al. (2005), Ravel et al. (2006), Carvalho et al. 
(2006) and Lin et al. (2007) in that the gr/gr microdeletion, at least in our 
population, are neutral variants with no phenotypic effect. There is a pressing 
need for Y-chromosome haplogroup and gr/gr analysis in large groups of 
normospermic and azoo/oligozoospermic men of different ethnic origins to 
characterize and explore the role played by this type of microdeletion in male 
infertility. Moreover, performing Southern blot analysis on the DAZ genes or 
quantitative DAZ copy assay (real-time PCR) and DAZ-SNV, at least in our 
gr/gr deletion pattern positive cases, to determine the RNA–binding motif 
(RBM) copy number in the various DAZ genes and DAZ copy number, in 
order to prove or exclude the possibility of del/dup AZFc model or ascertaining 
DAZ gene doublet deletion in these cases, respectively. In addition, sequence 
tagged sites +/- (+/- STS) PCR AZFc classification scheme may need further 
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refinement to exclude the possibility of a polymorphic loss of a single marker 

















       The main aim of the study was to determine the prevalence of numerical 
and structural chromosomal abnormalities among idiopathic azoospermic and 
oligozoospermic infertile males in Gaza Strip. The conclusions that have been 
drawn from the present study include: 
• The overall prevalence of genetic abnormalities at the cytogenetic level 
in Gazian Palestinian infertile population is 9.4%, urging the inclusion 
of cytogenetic testing in each diagnostic workup of any infertile man. 
• Klinefelter's syndrome is the most prevalent genetic cause of male 
infertility in our population and that this syndrome is not always 
associated with SCO. 
• The specific combination of azoospermia, very high FSH and LH, small 
testes, tall stature, low or low-normal testosterone and reduced seminal 
fluid volume may predict the XXY phenotype. 
• FSH levels are in direct relationship with degree of spermatogenic 
failure. 
• The frequency of classical AZF deletions is very low in our studied 
patients; consequently, inclusion of the AZF classical microdeletion 
assay in male infertility workup in our population is obviously 
questionable. 
• Hormonal data are not useful in predicting cases with lone absence of 
sY1291. 
• In our population, gr/gr partial AZFc deletions are not associated with 
spermatogenic failure. 
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6.2 Recommendations 
       According to the results and observations of the current study we 
recommend  the followings: 
1- Cytogenetic testing is mandatory and should be included in any male 
infertility diagnostic workup. 
2- Testicular biopsies and/or TESE should be warranted for all 
Klinefelter's syndrome patients, as they are representing a non-
homogenous group. 
3- There is a pressing and urgent need for defining Y-chromosome 
haplogroups in our Palestinian population, in both infertile and fertile 
groups. 
4- Using gene-specific markers instead of anonymous STSs as an 
alternative approach of testing Y-chromosome microdeletions should 
be initiated to detect deletions or mutations that may escape detection, 
or lying upstream or downstream the adopted STSs. 
5- We recommend the extension of this study using FISH, Southern blot, 
and quantitative DAZ copy assay for the gr/gr deletion pattern cases. 
6- Employing Southern blot analysis, DAZ-SNV analysis, and quantitative 
DAZ assay on our gr/gr deleted pattern cases to ascertain whether 
they are due to DAZ gene deletion, or either due to polymorphic loss of 
sY1291 and/or del/dup AZFc model. 
7-  Defining Y haplogroup(s) of our gr/gr deleted pattern cases to explore 
if they are associated with certain Y haplogroup(s) or not. 
8- +/- STS AZFc classification scheme should be revised and refined to 
exclude the possibility of polymorphic loss of a single locus. 
9- Search for other genetic, epigenetic, nutritional and environmental 
factors causing male infertility in our region should be promptly granted. 
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